<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Journal of Neural Transmission via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Journal of Neural Transmission' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Journal+of+Neural+Transmission&t=Journal+of+Neural+Transmission&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 20:43:12 +0100</lastBuildDate>
        <item>
            <title>Cathechol-O-methyltransferase Val158Met polymorphism is associated with disruptive behavior disorders among children and adolescents with ADHD</title>
            <link>http://www.medworm.com/index.php?rid=5639504&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg226t0216v46531t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 COMT Val
 
 158
 
 Met polymorphism has been associated with both symptoms of attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior
 disorders (DBD): that is, oppositional defiant disorder (ODD) and conduct disorder (CD) often comorbid with ADHD. The aim
 of this study was to test the association between COMT Val
 
 158
 
 Met polymorphism and the presence of DBD in children with ADHD (n&amp;nbsp;=&amp;nbsp;516). Homozygous Val/Val children showed a higher prevalence of ADHD comorbid with DBD (χ
 2&amp;nbsp;=&amp;nbsp;5.762; p&amp;nbsp;=&amp;nbsp;0.016; OR&amp;nbsp;=&amp;nbsp;1.58; CI95%&amp;nbsp;=&amp;nbsp;1.07–2.35). Our findings replicate previous results and suggest a role for COMT in the etiology of DBD in children and
 adolescents with ADHD.
 
 
	Content Type Journal ArticleCatego...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639504</comments>
            <pubDate>Tue, 24 Jan 2012 06:50:16 +0100</pubDate>
            <guid isPermaLink="false">5639504</guid>        </item>
        <item>
            <title>Modulation of in vivo GABA-evoked responses by nitric oxide-active compounds in the globus pallidus of rat</title>
            <link>http://www.medworm.com/index.php?rid=5621269&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq14123444k1rh7p2%2F</link>
            <description>In this study, we applied microiontophoresis to extracellular
 in vivo recordings to investigate the effect of NO-active compounds on GABA-evoked responses in the globus pallidus (GP) of
 anesthetized rats. The changes induced by NO-active drugs on the GABA-induced inhibition were used as indicators of NO modulation.
 The response to GABA release was tested on recorded GP neurons before and during the administration of S-nitroso-glutathione (SNOG, a NO donor) and/or Nω-nitro-l-arginine methyl ester (l-NAME), an inhibitor of nitric oxide synthase (NOS); furthermore, SNOG and l-NAME were tested at different ejection currents in order to highlight the possibility of a current-dependent effect in the
 nitrergic modulation of GABA transmission. In general, during SNOG ejection the magnitude of...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621269</comments>
            <pubDate>Thu, 19 Jan 2012 06:58:55 +0100</pubDate>
            <guid isPermaLink="false">5621269</guid>        </item>
        <item>
            <title>The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications</title>
            <link>http://www.medworm.com/index.php?rid=5621270&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8837878733v27531%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tryptophan is one of the essential amino acids, 80% of which is catabolised in the extrahepatic tissues by indoleamine-2,3-dioxygenase
 (IDO), the rate-limiting enzyme of the kynurenine pathway. Metabolites along the kynurenine pathway have been implicated to
 play a role in the pathomechanism of neuroinflammatory and neurodegenerative disorders. Changes in the concentration levels
 of kynurenines can shift the balance to pathological conditions. The ability to influence the metabolism towards the neuroprotective
 branch of the kynurenine pathway, i.e. towards kynurenic acid (KYNA) synthesis, may be one option in preventing neurodegenerative
 diseases. Three potential therapeutic strategies could be feasible to develop drugs to live up to expectations: (1) chemically
 r...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621270</comments>
            <pubDate>Thu, 19 Jan 2012 06:58:54 +0100</pubDate>
            <guid isPermaLink="false">5621270</guid>        </item>
        <item>
            <title>Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment</title>
            <link>http://www.medworm.com/index.php?rid=5584658&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa62386qv327924r8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hemifacial spasm is characterized by intermittent tonic or clonic contractions of the muscles supplied by the facial nerve.
 Although vision is less impaired than in patients with blepharospasm, the disease can impose significant psychosocial burden
 on patient’s life. Botulinum toxin (BoNT) is the well-established pharmacotherapy of choice, but evidence from controlled
 clinical trials is sparse. There is a broad variety of rating scales used in clinical studies with BoNT and obviously no consensus
 has been reached how to assess treatment outcome in hemifacial spasm. Clinical rating scales focusing on objective function
 were used in a couple of controlled studies with BoNT and were appropriate to discriminate between BoNTA and placebo. But
 it has not been shown th...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5584658</comments>
            <pubDate>Mon, 09 Jan 2012 19:35:25 +0100</pubDate>
            <guid isPermaLink="false">5584658</guid>        </item>
        <item>
            <title>Development of Parkinson’s disease in patients with Narcolepsy</title>
            <link>http://www.medworm.com/index.php?rid=5584660&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8303832241rq1573%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although amphetamine drugs can damage dopaminergic axons, it is unknown whether chronic treatment with amphetamine increases
 the risk of developing Parkinson’s disease (PD). Of 1,152 consecutive PD patients, 3 had a prior diagnosis of narcolepsy.
 This rate is five times higher than expected (p&amp;nbsp;=&amp;nbsp;0.02). These patients had typical onset of narcolepsy and underwent treatment with amphetamine. Although preliminary, this
 observation raises the possibility that some factors intrinsic to narcolepsy or its treatment may be a risk factor for PD.
 
 
	Content Type Journal ArticleCategory Movement Disorders - Short communicationPages 1-3DOI 10.1007/s00702-011-0761-zAuthors
		Chadwick W. Christine, Department of Neurology, University of California, San Francisco, 400...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5584660</comments>
            <pubDate>Mon, 09 Jan 2012 19:35:21 +0100</pubDate>
            <guid isPermaLink="false">5584660</guid>        </item>
        <item>
            <title>Changes of hand preference in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5584659&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhp185276h175x148%2F</link>
            <description>This study focused on the difference between pre-morbid and current hand preference of patients with Parkinson’s disease (PD).
 A survey instrument comprised items measuring pre-morbid and current hand preference and question related to the side of occurrence
 of initial symptoms. These questions were administered to 471 PD patients. The results show a significant change of pre-morbid
 right hand preference toward using the left when the side of PD onset was on the right hand and vice versa. Disease duration
 does not predict the amount of hand preference shift.
 
 
	Content Type Journal ArticleCategory Movement Disorders - Short communicationPages 1-4DOI 10.1007/s00702-011-0759-6Authors
		Jan Štochl, Department of Kinanthropology, Charles University in Prague, Jose Martiho 31, 162 52 P...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5584659</comments>
            <pubDate>Mon, 09 Jan 2012 19:35:21 +0100</pubDate>
            <guid isPermaLink="false">5584659</guid>        </item>
        <item>
            <title>A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study</title>
            <link>http://www.medworm.com/index.php?rid=5584661&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp572n577571u5124%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The concentration of kynurenic acid (KYNA) in the cerebrospinal fluid, which is in the nanomolar range, is known to decrease
 in epilepsy. The experimental data suggest that treatment with l-KYN dose dependently increases the concentration of the neuroprotective KYNA in the brain, which itself hardly crosses the
 blood–brain barrier. However, it is suggested that new synthetic KYNA analogs may readily cross the blood–brain barrier. In
 this study, we tested the hypothesis that a new KYNA analog administered systemically in a sufficient dose results in a decreased
 population spike activity recorded from the pyramidal layer of area CA1 of the hippocampus, and also provides protection against
 pentylenetetrazole-induced epileptiform seizures.
 
 
	Content Type Journal...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5584661</comments>
            <pubDate>Mon, 09 Jan 2012 19:35:20 +0100</pubDate>
            <guid isPermaLink="false">5584661</guid>        </item>
        <item>
            <title>Does pre-exposure inhibit fear context conditioning? A Virtual Reality Study</title>
            <link>http://www.medworm.com/index.php?rid=5573043&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl3208h23874v5736%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several studies in animals and humans have indicated that familiarity toward cues reduces cue-conditioning effects. The influence
 of familiarity of a context on context conditioning has been confirmed in animal studies only. Thus, this study examined contextual
 fear conditioning in humans depending on pre-exposure to the to-be-conditioned context. To accomplish this, a virtual reality
 paradigm presented via a head mounted display was realized. During conditioning, participants were exposed to one of two office
 rooms (contexts), of which one became associated with aversive electric stimuli (UCS). 1&amp;nbsp;day before conditioning, participants
 were randomly exposed to either the later to-be-conditioned context (n&amp;nbsp;=&amp;nbsp;20) or to an unrelated virtual environment (...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573043</comments>
            <pubDate>Fri, 06 Jan 2012 16:49:14 +0100</pubDate>
            <guid isPermaLink="false">5573043</guid>        </item>
        <item>
            <title>Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid</title>
            <link>http://www.medworm.com/index.php?rid=5573044&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv09p44v1x2237503%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been demonstrated that experiences taking place early in life have a profound influence on brain development, interacting
 with the genetic background and determining differences in the vulnerability to the onset of bipolar disorder when the individual
 is exposed to a second adverse event later in life. Here, we investigated the effects of exposure to an early adverse life
 event (maternal deprivation) and to a later adverse life event [d-amphetamine (AMPH)] on cognition in an animal model of mania. We have previously demonstrated that that repeated AMPH exposure
 produces severe and persistent cognitive impairment, which was more pronounced when the animals were maternal deprived, suggesting
 that the early adverse life event could be potentiating the effects o...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573044</comments>
            <pubDate>Wed, 04 Jan 2012 16:59:44 +0100</pubDate>
            <guid isPermaLink="false">5573044</guid>        </item>
        <item>
            <title>Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice</title>
            <link>http://www.medworm.com/index.php?rid=5573045&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl0338818162637mj%2F</link>
            <description>In conclusion, the present study suggests that sildenafil may enhance the activity of antidepressant drugs which
 exhibit cholinolytic activity.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Original ArticlePages 1-8DOI 10.1007/s00702-011-0756-9Authors
		Katarzyna Socała, Department of Animal Physiology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, PolandDorota Nieoczym, Department of Animal Physiology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, PolandElżbieta Wyska, Department of Pharmacokinetics and Physical Pharmacy, Collegium Medicum, Jagiellonian University, Kraków, PolandEwa Poleszak, Chair and Department of Applied Ph...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573045</comments>
            <pubDate>Wed, 04 Jan 2012 06:57:58 +0100</pubDate>
            <guid isPermaLink="false">5573045</guid>        </item>
        <item>
            <title>Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery</title>
            <link>http://www.medworm.com/index.php?rid=5573046&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F411318x3746kv228%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is usually assumed that kynurenic acid (KYNA) modifies neuronal function because it antagonizes the glycine site of the
 NMDA receptors and/or the neuronal cholinergic α7 nicotine receptors. It is not clear, however, whether the basal levels of
 KYNA found in brain extracellular spaces are sufficient to interact with these targets. Another reported target for KYNA is
 GPR35, an orphan receptor negatively coupled to Gi proteins. GPR35 is expressed both in neurons and other cells (including glia, macrophages and monocytes). KYNA affinity for
 GPR35 in native systems has not been clarified and the low-affinity data widely reported in the literature for the interaction
 between KYNA and human or rat GPR35 have been obtained in modified expression systems. Possibly by in...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573046</comments>
            <pubDate>Wed, 04 Jan 2012 06:57:56 +0100</pubDate>
            <guid isPermaLink="false">5573046</guid>        </item>
        <item>
            <title>(−)-Epigallocatechin-3-gallate increases the number of neural stem cells around the damaged area after rat traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=5573047&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa0lv5l32u8425232%2F</link>
            <description>In this study, male Wistar rats that had access to normal drinking water, or water containing 0.1% (w/v) EGCG, ad libitum
 received TBI at 10&amp;nbsp;weeks of age. Immunohistochemistry revealed that the number of nestin-positive cells around the damaged
 area after TBI in the EGCG treatment group increased significantly compared with the normal water group (P&amp;nbsp;&amp;lt;&amp;nbsp;0.05). However, the number of 8-hydroxy-2′-deoxyguanosine-, 4-hydroxy-2-nonenal-, single-stranded DNA (ssDNA)-positive
 cells and the level of peroxidation around the damaged area after TBI significantly decreased in the EGCG treatment group
 when compared with the water group (P&amp;nbsp;&amp;lt;&amp;nbsp;0.05). Furthermore, in contrast to the EGCG group, almost all ssDNA-positive cells in the water group co-localized with
 NeuN an...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573047</comments>
            <pubDate>Tue, 03 Jan 2012 06:44:13 +0100</pubDate>
            <guid isPermaLink="false">5573047</guid>        </item>
        <item>
            <title>Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases</title>
            <link>http://www.medworm.com/index.php?rid=5573048&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2287u640k05n1833%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The continuous production and efflux of reactive oxygen/nitrogen species from endogenous and exogenous sources can damage
 biological molecules and initiate a cascade of events. Mitochondria are pivotal in controlling cell survival and death. Cumulative
 oxidative stress, disrupted mitochondrial respiration, and mitochondrial damage are related with various neurodegenerative
 disorders, including Alzheimer’s disease, Parkinson’s disease, and others. Biochemical cascades of apoptosis are mediated
 in signaling molecules, including protein kinases and transcription factors. The expressions in the pro-apoptotic signal transduction
 networks may indeed promote cell death and degeneration in brain cells. The regulation of that protein phosphorylation by
 kinases and phos...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573048</comments>
            <pubDate>Tue, 03 Jan 2012 06:44:12 +0100</pubDate>
            <guid isPermaLink="false">5573048</guid>        </item>
        <item>
            <title>Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells</title>
            <link>http://www.medworm.com/index.php?rid=5553295&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F34704363h5270580%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The key pathological feature of Parkinson’s disease (PD) is selective degeneration of the neuromelanin (NM)-pigmented dopaminergic
 neurons in the substantia nigra (SN). NM, like other risk factors, such as oxidative stress (OS) and α-synuclein (α-syn),
 is involved in the pathogenesis of PD. But whether or not NM synergizes with α-syn or OS in the pathogenesis of PD remains
 unexplored. In the present study, we examined the effects of NM on cellular viability, apoptosis and free radical production
 in α-syn over-expressing human neuroblastoma cell line (SK-N-SH) in the presence or absence of the oxidizer Fenton’s Reagent
 (FR). We showed that NM synergized with FR in suppressing cell viability, and in inducing apoptosis and hydroxyl radical production
 in all S...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5553295</comments>
            <pubDate>Mon, 26 Dec 2011 16:46:36 +0100</pubDate>
            <guid isPermaLink="false">5553295</guid>        </item>
        <item>
            <title>Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats</title>
            <link>http://www.medworm.com/index.php?rid=5553296&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh686802833624472%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Targeting mechanisms that result in increased concentrations of kynurenic acid (KYNA) in the brain has been considered as
 a therapeutic approach for the treatment of epilepsy and certain neurodegenerative disorders. Recently, KYNA has been implicated
 in the effects produced by the high-fat and low-protein/carbohydrate ketogenic diet (KD) in a report demonstrating an increased
 production of KYNA in vitro by one of the ketone bodies, β-hydroxybutyrate, elevated by the KD. To further explore this association,
 brain concentrations of KYNA were compared in young (3&amp;nbsp;weeks old) and adult (8–10&amp;nbsp;weeks old) rats that were chronically exposed
 to the KD and regular diet. Exposure to the KD resulted in the anticipated elevations of β-hydroxybutyrate with accompany...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5553296</comments>
            <pubDate>Mon, 26 Dec 2011 16:46:35 +0100</pubDate>
            <guid isPermaLink="false">5553296</guid>        </item>
        <item>
            <title>Olfaction in child and adolescent anorexia nervosa</title>
            <link>http://www.medworm.com/index.php?rid=5526955&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4516032172570k08%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Previous studies indicate disturbed olfactory functions in anorexia nervosa with presumable relationship to the clinical symptom
 of food aversion and weight loss. However, these studies are in part limited due to inadequately matched control samples,
 insufficient exclusion criteria, complex interactions of the olfactory and trigeminal system, and the lack of regard to co-morbidity
 and medication. Thus, we investigated olfactory function in 26 female adolescent patients with anorexia nervosa and 23 healthy
 controls matched for age, gender, handedness, and intelligence. No significant group differences were identified. Controlling
 for co-morbid disorders, psychopharmacological treatment, and depressivity revealed superior olfactory identification performance
 in the ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5526955</comments>
            <pubDate>Mon, 19 Dec 2011 16:51:46 +0100</pubDate>
            <guid isPermaLink="false">5526955</guid>        </item>
        <item>
            <title>Reversal of stress-induced dendritic atrophy in the prefrontal cortex by intracranial self-stimulation</title>
            <link>http://www.medworm.com/index.php?rid=5516346&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1078251367173j75%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The mammalian prefrontal cortex (PFC) has been implicated in a variety of motivational and emotional processes underlying
 working memory, attention and decision making. The PFC receives dopaminergic projections from the ventral tegmental area (VTA)
 and contains high density of D1 and D2 receptors and these projections are important in higher integrative cortical functions.
 The neurons of the PFC have been shown to undergo atrophy in response to stress. In an earlier study, we demonstrated that
 the chronic stress-induced atrophy of hippocampal neurons and behavioral impairment in the T-maze task were reversed by the
 activation of dopaminergic pathway by intracranial self-stimulation (ICSS) of the VTA. The stress-induced decrease in hippocampal
 dopamine (DA) levels ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516346</comments>
            <pubDate>Tue, 13 Dec 2011 17:06:21 +0100</pubDate>
            <guid isPermaLink="false">5516346</guid>        </item>
        <item>
            <title>Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats</title>
            <link>http://www.medworm.com/index.php?rid=5506733&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1276080w526pt023%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pneumococcal meningitis is a severe infectious disease of the central nervous system, associated with acute inflammation and
 might cause damage to the host, such as deafness, blindness, seizure, and learning deficits. However, infectious diseases
 can play a significant role in the etiology of neuropsychiatric disturbances. In this context, we evaluated depressive-like
 parameters; corticosterone and ACTH levels in pneumococcal meningitis surviving rats. Wistar rats underwent a magna cistern
 tap receiving either 10&amp;nbsp;μL sterile saline or a Streptococcus pneumoniae suspension at the concentration of 5&amp;nbsp;×&amp;nbsp;109&amp;nbsp;cfu/mL. After 3&amp;nbsp;days of meningitis induction procedure, the animals were treated with imipramine at 10&amp;nbsp;mg/kg or saline for
 14&amp;nbsp;da...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5506733</comments>
            <pubDate>Mon, 12 Dec 2011 17:06:18 +0100</pubDate>
            <guid isPermaLink="false">5506733</guid>        </item>
        <item>
            <title>Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson’s disease-dementia: which matters most?</title>
            <link>http://www.medworm.com/index.php?rid=5506734&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F84twp5q238x0v1t2%2F</link>
            <description>In conclusion, the use of an extensive neuropsychological battery is still recommended
 in the diagnosis of dementia in PD.
 
 
	Content Type Journal ArticleCategory Movement Disorders - Original ArticlePages 1-8DOI 10.1007/s00702-011-0733-3Authors
		Francesca Di Biasio, “Sapienza,” University of Rome, Rome, ItalyNicola Vanacore, National Institute of Health (ISS), Rome, ItalyAlfonso Fasano, Gemelli Hospital, Catholic University of Sacred Heart, Rome, ItalyNicola Modugno, Neuromed Institute, “Sapienza,” University of Rome, Rome, ItalyBarbara Gandolfi, Neuromed Institute, “Sapienza,” University of Rome, Rome, ItalyFrancesco Lena, Catholic University of Sacred Heart, Campobasso, ItalyGiovanni Grillea, Neuromed Institute, “Sapienza,” University of Rome, Rome, ItalySara Pietrac...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5506734</comments>
            <pubDate>Mon, 12 Dec 2011 17:06:17 +0100</pubDate>
            <guid isPermaLink="false">5506734</guid>        </item>
        <item>
            <title>Effect of the calcineurin inhibitor FK506 on K+–Cl− cotransporter 2 expression in the mouse hippocampus after kainic acid-induced status epilepticus</title>
            <link>http://www.medworm.com/index.php?rid=5495937&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn50n11w115414611%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Calcineurin (CaN)-mediated excitotoxicity impairs γ-aminobutyric acid (GABA) transmission and induces neuronal apoptosis.
 Ca2+-dependent K+–Cl− cotransporter 2 (KCC2) participates in GABAergic inhibitory transmission. However, the mechanism by which CaN mediates GABA
 receptor-mediated KCC2 in seizures is not fully understood. In the present study, we investigated the altered expression of
 KCC2 and the effects of the CaN inhibitor FK506 on KCC2 expression in the mouse hippocampus following kainic acid (KA) treatment.
 FK506 was injected twice 24&amp;nbsp;h and 30&amp;nbsp;min before KA treatment and then mice were treated with KA and killed 2&amp;nbsp;days later. FK506
 had anticonvulsant effect on KA-induced seizure activities. CaN cleavage was evident in the hippocampus 24...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495937</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:18 +0100</pubDate>
            <guid isPermaLink="false">5495937</guid>        </item>
        <item>
            <title>Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect</title>
            <link>http://www.medworm.com/index.php?rid=5495938&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61x447366730451r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cannabinoids affect positive and negative affective experience and emotional perception, possibly by modulating limbic brain
 reactivity. In this double-blind crossover, placebo-controlled functional magnetic resonance imaging study in humans, an acute
 oral dose of &amp;#8710;9-tetrahydrocannabinol (THC) attenuated subgenual anterior cingulate cortex (sgACC) reactivity during the induction of negative
 affect. This observation extends prior findings implicating a cortico-limbic, emotion-related central mechanism underlying
 cannabinoid function.
 
 
	Content Type Journal ArticleCategory Biological Psychiatry - Short communicationPages 1-7DOI 10.1007/s00702-011-0747-xAuthors
		Christine A. Rabinak, Department of Psychiatry, University of Michigan, Rachel Upjohn Building, 42...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495938</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:17 +0100</pubDate>
            <guid isPermaLink="false">5495938</guid>        </item>
        <item>
            <title>Kynurenines and the nervous system: therapeutic perspectives</title>
            <link>http://www.medworm.com/index.php?rid=5495940&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcl546376t228748t%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-1DOI 10.1007/s00702-011-0748-9Authors
		László Vécsei, Department of Neurology, Faculty of Medicine Albert Szent-Györgyi Clinical Center, University of Szeged, Semmelweis u. 6, Szeged, 6725 Hungary
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495940</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:15 +0100</pubDate>
            <guid isPermaLink="false">5495940</guid>        </item>
        <item>
            <title>Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms</title>
            <link>http://www.medworm.com/index.php?rid=5495939&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5388646224t47045%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Heavy smoking and schizophrenia are diversely associated with nicotinic acetylcholine receptor expression, as was shown for
 brain and lymphocytes. Most studies so far have not systematically differentiated between schizophrenia smokers and non-smokers
 and were confined either to in vivo or post-mortem study approaches. In order to avoid variable in vivo influences or post-mortem
 bias, we used stably transformed B-lymphoblast cultures derived from healthy and schizophrenia subjects stratified for smoking
 versus non-smoking in order to differentiate these clinical conditions with regard to nicotinic acetylcholine receptor expression
 and regulation. Receptor quantities were measured using [3H]-nicotine and [3H]-epibatidine binding. At baseline, [3H]-nicotine binding w...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495939</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:15 +0100</pubDate>
            <guid isPermaLink="false">5495939</guid>        </item>
        <item>
            <title>MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs</title>
            <link>http://www.medworm.com/index.php?rid=5488492&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F22797672k7141343%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Schizophrenia is a debilitating mental disorder with a global prevalence of 1% and its etiology remains poorly understood.
 In the current study we investigated the influence of antipsychotic drugs on the effects of MK-801 administration, which is
 a drug that mimics biochemical changes observed in schizophrenia, on Na+, K+-ATPase activity and some parameters of oxidative stress in zebrafish brain. Our results showed that MK-801 treatment significantly
 decreased Na+, K+-ATPase activity, and all antipsychotics tested prevented such effects. Acute MK-801 treatment did not alter reactive oxygen/nitrogen
 species by 2′7′-dichlorofluorscein (H2DCF) oxidation assay, but increased the levels of thiobarbituric acid reactive substances
 (TBARS), when compared with controls....</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488492</comments>
            <pubDate>Mon, 05 Dec 2011 17:42:28 +0100</pubDate>
            <guid isPermaLink="false">5488492</guid>        </item>
        <item>
            <title>Compensatory brain activation in children with attention deficit/hyperactivity disorder during a simplified Go/No-go task</title>
            <link>http://www.medworm.com/index.php?rid=5477997&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg0655mj06l476480%2F</link>
            <description>In this study, 15 ADHD children and 15 sex-, age-, and IQ-matched control
 children were scanned with a 3-T MRI equipment while performing a simplified letter Go/No-go task. The results showed more
 brain activation in the ADHD group compared with the control group, whereas the accuracy and reaction time of behavioral performance
 were the same. Children with ADHD did not activate the normal RI brain circuits, which are thought to be predominantly located
 in the right middle/inferior frontal gyrus (BA46/44), right inferior parietal regions (BA40), and pre-SMA(BA6), but instead,
 activated brain regions, such as the left inferior frontal cortex, the right inferior temporal cortex, the right precentral
 gyrus, the left postcentral gyrus, the inferior occipital cortex, the middle occipital c...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477997</comments>
            <pubDate>Fri, 02 Dec 2011 17:14:07 +0100</pubDate>
            <guid isPermaLink="false">5477997</guid>        </item>
        <item>
            <title>The role of the kynurenine metabolism in major depression</title>
            <link>http://www.medworm.com/index.php?rid=5477998&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp101726p20616183%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There are circumferential evidences that major depression is associated with mild pro-inflammatory state. Both physiological
 and psychological stress can induce increased production of pro-inflammatory mediators, reactive oxygen species (ROS) and
 hypothalamo–hypophyseal–adrenal axis disturbances. While both pro-inflammatory mediators and ROS could activate the tryptophan
 breakdown and kynurenine pathway with a shift toward the neurotoxic arm, chronic hypercortisolism could also enhance tryptophan
 breakdown and induce neurodegenerative changes. The imbalanced kynurenine metabolism in terms of neuroprotective and neurotoxic
 effects was demonstrated in major depression, and in drug-induced neuropsychiatric side effects, such as interferon-treated
 depression. The ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477998</comments>
            <pubDate>Fri, 02 Dec 2011 17:14:06 +0100</pubDate>
            <guid isPermaLink="false">5477998</guid>        </item>
        <item>
            <title>Involvement of immunologic and biochemical mechanisms in the pathogenesis of Tourette’s syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5477999&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7357226255148477%2F</link>
            <description>This study sought to investigate the possible correlation of several immunological
 and biochemical markers with Tourette’s syndrome. Children with Tourette’s syndrome attending a tertiary pediatric medical
 center from May 2008 to April 2010, and healthy age-matched control subjects underwent a comprehensive biochemical and immunological
 work-up. Demographic data were abstracted from the medical records. Findings were compared between the groups and analyzed
 statistically. Sixty-eight children with Tourette’s syndrome (58 males, 85.3%) and 36 healthy children (25 males, 69.4%) were
 recruited. Compared with the control group, the Tourette’s syndrome group had significantly higher levels of ferritin (p&amp;nbsp;=&amp;nbsp;0.01) and hemoglobin (p&amp;nbsp;=&amp;nbsp;0.02), a lower level of zinc (...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477999</comments>
            <pubDate>Fri, 02 Dec 2011 17:14:05 +0100</pubDate>
            <guid isPermaLink="false">5477999</guid>        </item>
        <item>
            <title>Muscarinic acetylcholine receptor-mediated activation of Gq in rat brain membranes determined by guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assay</title>
            <link>http://www.medworm.com/index.php?rid=5470269&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fex18596458855505%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the present study, we performed antibody-capture guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) scintillation proximity assay (SPA), in which immuno-capture of Gα subunits following [35S]GTPγS binding was combined with SPA technology, in rat brain membranes. Preliminary experiments using a series of agonists
 and commercially available anti-Gα antibodies indicated the increase in specific [35S]GTPγS binding to Gαq determined with the anti-Gα antibody sc-393 and evoked by carbamylcholine chloride (CCh) was pharmacologically relevant.
 The experimental conditions were optimized as for the concentrations of GDP, MgCl2, and NaCl, the dilution of the anti-Gαq antibody, and membrane protein contents incubated. Under the optimized conditions, CCh-stimulated...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470269</comments>
            <pubDate>Wed, 30 Nov 2011 04:39:29 +0100</pubDate>
            <guid isPermaLink="false">5470269</guid>        </item>
        <item>
            <title>Recent rodent models for Alzheimer’s disease: clinical implications and basic research</title>
            <link>http://www.medworm.com/index.php?rid=5423716&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0u00685x63003864%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alzheimer’s disease (AD) is the most common origin of dementia in the elderly. Although the cause of AD remains unknown, several
 factors have been identified that appear to play a critical role in the development of this debilitating disorder. In particular,
 amyloid precursor protein (APP), tau hyperphosphorylation, and the secretase enzymes, have become the focal point of recent
 research. Over the last two decades, several transgenic and non-transgenic animal models have been developed to elucidate
 the mechanistic aspects of AD and to validate potential therapeutic targets. Transgenic rodent models over-expressing human
 β-amyloid precursor protein (β-APP) and mutant forms of tau have become precious tools to study and understand the pathogenesis
 of AD at the ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423716</comments>
            <pubDate>Tue, 15 Nov 2011 16:58:46 +0100</pubDate>
            <guid isPermaLink="false">5423716</guid>        </item>
        <item>
            <title>Basic cell physiological activities (cell adhesion, chemotaxis and proliferation) induced by selegiline and its derivatives in Mono Mac 6 human monocytes</title>
            <link>http://www.medworm.com/index.php?rid=5423717&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff0k461828q787r13%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Selegiline (R-deprenyl), a monoamine oxidase-B (MAO-B) inhibitor, has complex pharmacological effect that contributes to treatment of neurodegenerative
 diseases such as Parkinson’s and presumably Alzheimer’s disease and might work as an inhibitor of tumor growth. In respect
 of tumorigenesis and metastasis formation, the controlled modifications of adhesion and migration have high therapeutic significance.
 In the present study, our purpose was to investigate cell physiological responses (adhesion, chemotaxis and proliferation)
 induced by selegiline, its metabolites and synthetic derivatives and to find some correlations between the molecular structure
 and the reported antitumor behavior of the derivatives. Our results demonstrated that both R- and S-deprenyls ha...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423717</comments>
            <pubDate>Tue, 15 Nov 2011 16:58:45 +0100</pubDate>
            <guid isPermaLink="false">5423717</guid>        </item>
        <item>
            <title>Intra- and inter-cortical motor excitability in Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5410435&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8737w50g768814j2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Transcranial magnetic stimulation (TMS) provides evidence for facilitatory and inhibitory motor dysfunctions in Alzheimer’s
 disease (AD). The corpus callosum (CC) is affected in AD already at early stages consistent with the hypothesis that AD patients
 exhibit alterations in transcallosally mediated motor inhibition (ipsilateral silent period, iSP). Therefore, here we aimed
 at investigating the integrity not only of intra-, but also of inter-hemispheric mechanisms of cortical motor excitability
 in AD. We determined the iSP, the resting motor threshold (RMT), and the amplitude of motor evoked potentials (MEP) in 19
 AD patients and 19 healthy controls using single-pulse TMS. Furthermore, we used paired-pulse TMS to study the intra-cortical
 inhibition (ICI) and int...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410435</comments>
            <pubDate>Sat, 12 Nov 2011 16:53:49 +0100</pubDate>
            <guid isPermaLink="false">5410435</guid>        </item>
        <item>
            <title>Mechanisms underlying and medical management of l-Dopa-associated motor complications</title>
            <link>http://www.medworm.com/index.php?rid=5410436&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8v7863668136t411%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00702-011-0728-0Authors
		Manfred Gerlach, Laboratory for Clinical Neurobiology, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Füchsleinstrasse 15, 97080 Würzburg, GermanyPeter Riederer, Laboratory for Clinical Neurochemistry, Department of Psychiatry, Psychosomatics and Psychotherapy, National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research, University of Würzburg, Füchsleinstrasse 15, 97080 Würzburg, GermanyDieter Scheller, Department Pharmacology of Parkinson’s Disease and Movement Disorders, CNS Research UCB Pharma S.A, Chemin Du Foriest, 1420 Braine l’Alleud, Belgium
	

	
		Journal Journal of Neural TransmissionOn...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410436</comments>
            <pubDate>Thu, 10 Nov 2011 16:51:36 +0100</pubDate>
            <guid isPermaLink="false">5410436</guid>        </item>
        <item>
            <title>Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms</title>
            <link>http://www.medworm.com/index.php?rid=5410437&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1g6w5857086m5j8%2F</link>
            <description>In conclusion, we identified several loci associated with AWS. These findings offer the potential for
 new insights into the pathogenesis of AD and AWS.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Original ArticlePages 1-9DOI 10.1007/s00702-011-0729-zAuthors
		Ke-Sheng Wang, Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, PO Box 70259, Lamb Hall, Johnson City, TN 37614-1700, USAXuefeng Liu, Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, PO Box 70259, Lamb Hall, Johnson City, TN 37614-1700, USAQunyuan Zhang, Division of Statistical Genomics, Washington University School of Medicine, St. Louis, MO 63108, USALong-Yang Wu, Department of...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410437</comments>
            <pubDate>Thu, 10 Nov 2011 06:46:41 +0100</pubDate>
            <guid isPermaLink="false">5410437</guid>        </item>
        <item>
            <title>On the origin of the triplet puzzle of homologies in receptor heteromers: toll-like receptor triplets in different types of receptors</title>
            <link>http://www.medworm.com/index.php?rid=5410438&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa32171l0568g1h36%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Based on our theory, we have discovered main triplets of amino acid residues in the GABAB1 receptor and several other neural
 receptors, which seem to originate from toll-like receptors and appear also as homologies in receptor heteromers. The obtained
 results strengthen our hypothesis that these triplets may ‘guide-and-clasp’ receptor–receptor interactions.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Original ArticlePages 1-7DOI 10.1007/s00702-011-0734-2Authors
		Alexander O. Tarakanov, St. Petersburg Institute for Informatics and Automation, Russian Academy of Sciences, Saint Petersburg, RussiaKjell G. Fuxe, Department of Neuroscience, Karolinska Institute, Stockholm, SwedenDasiel O. Borroto-Escuela, Department of Ne...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410438</comments>
            <pubDate>Tue, 08 Nov 2011 16:50:54 +0100</pubDate>
            <guid isPermaLink="false">5410438</guid>        </item>
        <item>
            <title>Instability of syllable repetition in progressive supranuclear palsy</title>
            <link>http://www.medworm.com/index.php?rid=5410441&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk222m5654222700m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dysarthria is a prominent feature of progressive supranuclear palsy (PSP) and consists—amongst other features—of impaired
 speech fluency. Since in Parkinson’s disease (PD) steadiness of syllable repetition in the course of the performance has been
 shown to be impaired, the aim of the present study was to investigate if measurement of syllable repetition shows similar
 or even more pronounced abnormalities in PSP. Thirty six patients with the clinical diagnosis of PSP (16 PSP-Richardson syndrome/PSP-RS
 and 20 PSP-parkinsonism/PSP-P), 60 patients with PD and 32 healthy speakers were tested. Participants had to repeat a single
 syllable in a self chosen isochronous pace. Percental coefficient of variance (COV) of interval length was measured for description
 of pa...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410441</comments>
            <pubDate>Mon, 07 Nov 2011 17:13:11 +0100</pubDate>
            <guid isPermaLink="false">5410441</guid>        </item>
        <item>
            <title>CSF biomarkers in different phenotypes of Parkinson disease</title>
            <link>http://www.medworm.com/index.php?rid=5410440&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbk717722w214146q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;CSF biomarker studies were performed in 6 patients each with tremor-dominant (TD) and non-tremor-dominant (NT) Parkinson disease
 (PD) patients, 27 Alzheimer disease (AD) and 17 age-matched controls. In both NT-PD and AD patients total tau levels and the
 cortex tau/Aβ-42 were significantly increased compared to both TD-PD patients and controls (p&amp;nbsp;&amp;lt;&amp;nbsp;0.01). These data in a small cohort confirm previous studies, corroborating the opinion that CSF levels of tau protein
 and the index total-tau/Aβ-42 may be potential markers of the severity of neurodegeneration in PD.
 
 
	Content Type Journal ArticleCategory Movement Disorders - Short communicationPages 1-2DOI 10.1007/s00702-011-0736-0Authors
		Kurt A. Jellinger, Wein, Austria
	

	
		Journal Journal of Neura...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410440</comments>
            <pubDate>Mon, 07 Nov 2011 17:13:11 +0100</pubDate>
            <guid isPermaLink="false">5410440</guid>        </item>
        <item>
            <title>Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase</title>
            <link>http://www.medworm.com/index.php?rid=5410439&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3936472k3154054k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rasagiline and (−)deprenyl (selegiline), irreversible type B monoamine oxidase (MAO-B) inhibitors, protect neuronal cells
 through gene induction of pro-survival Bcl-2 and neurotrophic factors in the cellular models of neurodegenerative disorders. In this paper, the role of MAO in the up-regulation
 of neuroprotective Bcl-2 gene by these inhibitors was studied using type A MAO (MAO-A) expressing wild SH-SY5Y cells and the transfection-enforced
 MAO-B overexpressed cells. Rasagiline and (−)deprenyl, and also befloxatone, a reversible MAO-A inhibitor, increased Bcl-2 mRNA and protein in SH-SY5Y cells. Silencing MAO-A expression with short interfering (si) RNA suppressed Bcl-2 induction
 by rasagiline, but not by (−)deprenyl. MAO-B overexpression inhibited Bcl-2 indu...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410439</comments>
            <pubDate>Mon, 07 Nov 2011 17:13:11 +0100</pubDate>
            <guid isPermaLink="false">5410439</guid>        </item>
        <item>
            <title>Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid</title>
            <link>http://www.medworm.com/index.php?rid=5410443&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh3737402l0080r3k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The main purpose of this study was to facilitate the delivery of kynurenic acid (KYNA) across the blood–brain barrier (BBB)
 by applying micelles as nanoscale containers. Non-ionic amphiphilic molecules were used for preparation of spherical micelles
 for delivery of kynurenic acid in aqueous solution in physiological condition. It was established that Triton X 100 and Lutensol
 AP 20 non-ionic surfactants are able to produce stable nanocontainers for delivery of kynurenic acid molecules. The incorporation
 of KYNA molecules was investigated by dynamic light scattering and the size of micelles were calculated between 5 and 10&amp;nbsp;nm
 in 150&amp;nbsp;mM NaCl and pH 7.5–7.6 solutions. Encapsulated kynurenic acid showed a significantly higher blood–brain barrier permeab...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410443</comments>
            <pubDate>Mon, 07 Nov 2011 17:13:10 +0100</pubDate>
            <guid isPermaLink="false">5410443</guid>        </item>
        <item>
            <title>Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains</title>
            <link>http://www.medworm.com/index.php?rid=5410442&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2118584270512013%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) arises from the loss of dopaminergic neurons in the substantia nigra. 1-Methyl-4-phenyl-1, 2, 3,
 6-tetrahydropyridine (MPTP) is well known to cause Parkinsonism in humans with neurotoxicity specific for dopaminergic neurons.
 The experience with MPTP supports the hypothesis that endogenous or xenobiotic neurotoxins are involved in the pathogenesis
 of PD in humans. In our study, 1-acetyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydro-isoquinoline (ADTIQ), a novel compound, was found
 in frozen human brain tissues. The formation of ADTIQ was demonstrated using dopamine and methylglyoxal under physiological
 conditions. Methylglyoxal is a by-product of glycolysis. ADTIQ and its precursors, dopamine and methylglyoxal, were detected
 in different regions o...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410442</comments>
            <pubDate>Mon, 07 Nov 2011 17:13:10 +0100</pubDate>
            <guid isPermaLink="false">5410442</guid>        </item>
        <item>
            <title>Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project</title>
            <link>http://www.medworm.com/index.php?rid=5410444&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1l542650064526r5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Altered glucose metabolism has been described in Alzheimer’s disease (AD). We re-investigated the interaction of the insulin
 (INS) and the peroxisome proliferator-activated receptor alpha (PPARA) genes in AD risk in the Epistasis Project, including 1,757 AD cases and 6,294 controls. Allele frequencies of both SNPs
 (PPARA L162V, INS intron 0 A/T) differed between Northern Europeans and Northern Spanish. The PPARA 162LL genotype increased AD risk in Northern Europeans (p&amp;nbsp;=&amp;nbsp;0.04), but not in Northern Spanish (p&amp;nbsp;=&amp;nbsp;0.2). There was no association of the INS intron 0 TT genotype with AD. We observed an interaction on AD risk between PPARA 162LL and INS intron 0 TT genotypes in Northern Europeans (Synergy factor 2.5, p&amp;nbsp;=&amp;nbsp;0.016), but not in Nort...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410444</comments>
            <pubDate>Mon, 07 Nov 2011 17:13:09 +0100</pubDate>
            <guid isPermaLink="false">5410444</guid>        </item>
        <item>
            <title>Synaptic protein expression is regulated by a pro-oxidant diet in APPxPS1 mice</title>
            <link>http://www.medworm.com/index.php?rid=5389906&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe378064977tj36n3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dietary factors may play a role in Alzheimer’s disease (AD) pathogenesis. In an effort to recapitulate some of the synaptic
 protein changes observed in the disease, AD transgenic and wild-type mice were fed either a normal or pro-oxidant diet for
 3&amp;nbsp;months from three months of age. Pro-oxidant diet treatment resulted in altered expression of vesicular glutamate transporter-1
 and glutamine synthetase, suggesting changes in glutamatergic synaptic function, and increased expression of urokinase plasminogen
 activator receptor, possibly reflecting oxidative stress.
 
 
	Content Type Journal ArticleCategory Dementias - Short communicationPages 1-4DOI 10.1007/s00702-011-0727-1Authors
		Martin Broadstock, King’s College London, Wolfson Centre for Age-Related Disease...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389906</comments>
            <pubDate>Fri, 04 Nov 2011 16:50:26 +0100</pubDate>
            <guid isPermaLink="false">5389906</guid>        </item>
        <item>
            <title>Short latency afferent inhibition differs among the subtypes of mild cognitive impairment</title>
            <link>http://www.medworm.com/index.php?rid=5349695&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc534uu275371488m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mild cognitive impairment (MCI) is considered a transitional stage between normal aging and a diagnosis of clinically probable
 Alzheimer disease (AD). The role of the cholinergic system in MCI is not clearly defined and needs to be further investigated.
 A transcranial magnetic stimulation (TMS) protocol, the short latency afferent inhibition (SAI), may give direct information
 about the function of some cholinergic pathways in the human motor cortex. We aimed to evaluate in the present study the relationship
 of SAI to the specific clinical subtypes of MCI. SAI was examined in 20 patients with amnestic MCI (10 SD, 10 MD), twenty
 patients with nonamnestic MCI (10 SD, 10 MD) and ten control subjects. Motor threshold, central motor conduction time, intracortical
 inhibi...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349695</comments>
            <pubDate>Fri, 21 Oct 2011 05:47:26 +0100</pubDate>
            <guid isPermaLink="false">5349695</guid>        </item>
        <item>
            <title>Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system</title>
            <link>http://www.medworm.com/index.php?rid=5338137&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcr3q5k4741071557%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Repeated stress engenders behavioral sensitization. The mesolimbic dopamine system is critically involved in drug-induced
 behavioral sensitization. In the present study we examined the differences between adolescent and adult rats in stress-induced
 behavioral sensitization to amphetamine and changes in dopamine (DA) and its metabolite levels in the mesolimbic system. Adolescent
 or adult rats were restrained for 2&amp;nbsp;h, once a day, for 7&amp;nbsp;days. Three days after the last exposure to stress, the animals were
 challenged with saline or amphetamine (1.0&amp;nbsp;mg/kg i.p.) and amphetamine-induced locomotion was recorded for 40&amp;nbsp;min. Immediately
 after the behavioral tests, rats were decapitated and the nucleus accumbens (NAcc), ventral tegmental area (VTA) and amyg...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338137</comments>
            <pubDate>Tue, 18 Oct 2011 06:00:14 +0100</pubDate>
            <guid isPermaLink="false">5338137</guid>        </item>
        <item>
            <title>The default mode network integrity in patients with Parkinson’s disease is levodopa equivalent dose-dependent</title>
            <link>http://www.medworm.com/index.php?rid=5325371&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcrxv16045475w035%2F</link>
            <description>We examined
 the DMN in PD patients on dopaminergic medication with normal cognitive performance compared to age- and gender-matched healthy
 controls (HC) using fMRI and three methodological procedures: independent component analysis of resting-state data, analysis
 of deactivation during a complex visual scene-encoding task, and seed-based functional connectivity analysis. In the PD group,
 we also studied the effect of dopaminergic medication on the DMN integrity. We did not find any difference between the PD
 and HC groups in the DMN, but using the daily levodopa equivalent dose as a covariate, we observed an enhanced functional
 connectivity of the DMN in the posterior cingulate cortex and decreased activation in the left parahippocampal gyrus during
 the cognitive task. We conclude t...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325371</comments>
            <pubDate>Fri, 14 Oct 2011 10:39:30 +0100</pubDate>
            <guid isPermaLink="false">5325371</guid>        </item>
        <item>
            <title>Modifications on the carboxylic function of kynurenic acid</title>
            <link>http://www.medworm.com/index.php?rid=5325372&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff146814673380q2q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pharmacological and histological studies of ten new amides of kynurenic acid revealed that N-(2-N,N-dimethylaminoethyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride has effective neuroprotective properties. Namely, this molecule is: (1) proved to be
 an effective inhibitor of excitatory synaptic transmission in the CA1 region of the hippocampus both in in vitro and ex vivo
 studies, (2) in four vessel occlusion model of transient global forebrain ischaemia, measuring the rate of hippocampal CA1
 pyramidal cell loss and preservation of long-term potentiation at Schaffer collateral-CA1 synapses, the neuroprotective potential
 was represented. N-(2-N,N-dimethylaminoethyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride administration significantly diminished hippocampal C...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325372</comments>
            <pubDate>Thu, 13 Oct 2011 15:46:51 +0100</pubDate>
            <guid isPermaLink="false">5325372</guid>        </item>
        <item>
            <title>Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors</title>
            <link>http://www.medworm.com/index.php?rid=5316877&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frh181563408n8r01%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The present study was designed to assess the role of 5-HT2A/2C receptors in the acute and repeated effect of clozapine and olanzapine in a rat conditioned avoidance response model, a validated
 model of antipsychotic activity. Male Sprague–Dawley rats that were previously treated with either phencyclidine (0.5–2.0&amp;nbsp;mg/kg,
 sc), amphetamine (1.25–5.0&amp;nbsp;mg/kg, sc), or saline and tested in a prepulse inhibition of acoustic startle study were used.
 They were first trained to acquire avoidance response to a white noise (CS1) and a pure tone (CS2) that differed in their
 ability to predict the occurrence of footshock. Those who acquired avoidance response were administered with clozapine (10.0&amp;nbsp;mg/kg,
 sc) or olanzapine (1.0&amp;nbsp;mg/kg, sc) together with eit...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316877</comments>
            <pubDate>Mon, 10 Oct 2011 15:06:10 +0100</pubDate>
            <guid isPermaLink="false">5316877</guid>        </item>
        <item>
            <title>ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5316878&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff367823838l18733%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vascular dementia is the second common cause of dementia, only second to Alzheimer’s disease in later life. The Apolipoprotein
 E (ApoE) gene polymorphism as a risk factor in vascular dementia has been suggested, but direct evidence from genetic association
 studies remains inconclusive even in Chinese population. Therefore, we performed this meta-analysis in order to evaluate the
 relationship between ApoE gene polymorphism and susceptibility to vascular dementia in Chinese population by pooling data
 from all relevant case–control studies published domestically and abroad from January 1990 to May 2011. 18 case–control studies
 were selected. Meta-analysis results showed that the pooled OR value of vascular dementia subjects in Chinese population with
 ε4 allele...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316878</comments>
            <pubDate>Sat, 08 Oct 2011 15:44:31 +0100</pubDate>
            <guid isPermaLink="false">5316878</guid>        </item>
        <item>
            <title>Measuring the potency labelling of onabotulinumtoxinA (Botox®) and incobotulinumtoxinA (Xeomin®) in an LD50 assay</title>
            <link>http://www.medworm.com/index.php?rid=5298203&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx656310x82120762%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The biological potency of botulinum toxin (BT) drugs is determined by a standardised LD50 assay. However, the potency labelling
 varies vary amongst different BT drugs. One reason for this may be differences in the LD50 assays applied. When five unexpired
 batches of onabotulinumtoxinA (Botox®) and incobotulinumtoxinA (Xeomin®) are compared in the Xeomin® batch release assay, the potency variability of both BT drugs fell within the range allowed by the European Pharmacopoiea.
 Statistical analyses failed to detect differences in the potency labelling of both products. Although the existence of a conversion
 ratio has been questioned recently, our experimental data are in line with previous clinical experience showing that Botox® and Xeomin® can be compared using a ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298203</comments>
            <pubDate>Wed, 05 Oct 2011 05:43:40 +0100</pubDate>
            <guid isPermaLink="false">5298203</guid>        </item>
        <item>
            <title>Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5287463&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh53481u52jpu0106%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mild cognitive impairment in Parkinson disease (PD-MCI) shows heterogeneity in the clinical presentation, neuropsychology,
 neuroimaging, and neuropathology, suggesting abnormal metabolic network activities involving several cortical and subcortical
 systems. Prospective studies using specific biomarkers, including amyloid imaging and CSF biomarkers are important for the
 diagnosis and prognostic assessment of early cognitive deficits in PD patients.
 
 
	Content Type Journal ArticleCategory Movement Disorders - Short communicationPages 1-2DOI 10.1007/s00702-011-0716-4Authors
		Kurt Jellinger, Institute of Clinical Neurobiology, Vienna, Austria
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287463</comments>
            <pubDate>Fri, 30 Sep 2011 05:52:07 +0100</pubDate>
            <guid isPermaLink="false">5287463</guid>        </item>
        <item>
            <title>A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP</title>
            <link>http://www.medworm.com/index.php?rid=5287462&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2p17431246571l68%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) is a neurodegenerative disorder frequent at old age characterized by atrophy of the nigrostriatal
 projection. Overexpression and A53T-mutation of the presynaptic, vesicle-associated chaperone alpha-synuclein are known to
 cause early-onset autosomal dominant PD. We previously generated mice with transgenic overexpression of human A53T-alpha-synuclein
 (A53T-SNCA) in dopaminergic substantia nigra neurons as a model of early PD. To elucidate the early and late effects of A53T-alpha-synuclein
 on the proteome of dopaminergic nerve terminals in the striatum, we now investigated expression profiles of young and old
 mice using two-dimensional fluorescence difference in gel electrophoresis (2D-DIGE) and mass spectrometry. In total, 15 proteins
 wer...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287462</comments>
            <pubDate>Fri, 30 Sep 2011 05:52:07 +0100</pubDate>
            <guid isPermaLink="false">5287462</guid>        </item>
        <item>
            <title>Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain</title>
            <link>http://www.medworm.com/index.php?rid=5275593&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4q62h42735qu016%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several studies have appointed for a role of glutamatergic system and/or mitochondrial function in major depression. In the
 present study, we evaluated the creatine kinase and mitochondrial respiratory chain activities after acute and chronic treatments
 with memantine (N-methyl-d-aspartate receptor antagonist) and imipramine (tricyclic antidepressant) in rats. To this aim, rats were acutely or chronically
 treated for 14&amp;nbsp;days once a day with saline, memantine (5, 10 and 20&amp;nbsp;mg/kg) and imipramine (10, 20 and 30&amp;nbsp;mg/kg). After acute
 or chronic treatments, we evaluated mitochondrial respiratory chain complexes (I, II, II–III and IV) and creatine kinase activities
 in prefrontal cortex, hippocampus and striatum. Our results showed that both acute and chron...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5275593</comments>
            <pubDate>Wed, 28 Sep 2011 05:51:28 +0100</pubDate>
            <guid isPermaLink="false">5275593</guid>        </item>
        <item>
            <title>Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia</title>
            <link>http://www.medworm.com/index.php?rid=5228098&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg1t331r678q04731%2F</link>
            <description>In conclusion, these findings strengthen previous data from our laboratory
 implicating glucocorticoid mechanisms in ECS-induced retrograde amnesia. We suggest that the administration of a selective
 glucocorticoid receptor antagonist shortly before electroconvulsive therapy (ECT) treatments may attenuate the deleterious
 effect of ECT-induced acute hypercortisolemia on neural mechanisms involved in learning and memory.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Original ArticlePages 1-8DOI 10.1007/s00702-011-0712-8Authors
		Chittaranjan Andrade, Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, 560 029 IndiaShahid Ahmad Shaikh, Department of Psychopharmacology, National Institute of Mental Heal...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228098</comments>
            <pubDate>Thu, 15 Sep 2011 15:48:30 +0100</pubDate>
            <guid isPermaLink="false">5228098</guid>        </item>
        <item>
            <title>A comparison of neurotoxicity in cerebellum produced by dermal application of chlorpyrifos in young and adult mice</title>
            <link>http://www.medworm.com/index.php?rid=5228099&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0h257416234h0222%2F</link>
            <description>In conclusion, this study confirmed
 that dermal exposure of CPF was able to exert neurotoxic effect in both young and adult mice. However, the quantitative results
 revealed that adult mice showed more GFAP expression in cerebellum when compared with the young, when exposed to CPF.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Original ArticlePages 1-8DOI 10.1007/s00702-011-0715-5Authors
		K. Krishnan, School of Pharmacy and Health Science, International Medical University, No. 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, MalaysiaN. K. Mitra, Department of Human Biology, School of Medicine, International Medical University, No. 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, MalaysiaL. S. Yee, School of Pharmacy and Health Science, I...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228099</comments>
            <pubDate>Thu, 15 Sep 2011 15:48:27 +0100</pubDate>
            <guid isPermaLink="false">5228099</guid>        </item>
        <item>
            <title>Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5211140&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu5v38k712730k06k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In Parkinson’s disease (PD), the effects of deep brain stimulation of the pedunculopontine nucleus (PPTg-DBS) on gait has
 been object of international debate. Some evidence demonstrated that, in the late swing-early stance phase of gait cycle,
 a reduced surface electromyographic activation (sEMG) of tibialis anterior (TA) is linked to the striatal dopamine deficiency
 in PD patients. In the present study we report preliminary results on the effect of PPTg-DBS on electromyographic patterns
 during gait in individual PD patients. To evaluate the sEMG amplitude of TA, the root mean square (RMS) of the TA burst in
 late swing-early stance phase (RMS-A) was normalized as a percent of the RMS of the TA burst in late stance-early swing (RMS-B).
 We studied three male patie...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211140</comments>
            <pubDate>Fri, 09 Sep 2011 05:45:26 +0100</pubDate>
            <guid isPermaLink="false">5211140</guid>        </item>
        <item>
            <title>Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death</title>
            <link>http://www.medworm.com/index.php?rid=5211138&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4n3702208351515u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) is the second most common neurodegenerative disorder and is characterized by a loss of dopaminergic
 neurons in the substantia nigra pars compacta. To discover potential key molecules in this process, we utilized cDNA microarray
 technology to obtain an expression profile of transcripts in MN9D dopaminergic neuronal cells treated with 6-hydroxydopamine.
 Using a self-organizing map algorithm, data mining and clustering were combined to identify distinct functional subgroups
 of genes. We identified alterations in the expression of 81 genes in eight clusters. Among these genes, we verified protein
 expression patterns of MAP kinase phosphatase 1 and sequestosome 1 using both cell culture and rat brain models of PD. Immunological
 analyses revea...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211138</comments>
            <pubDate>Fri, 09 Sep 2011 05:45:26 +0100</pubDate>
            <guid isPermaLink="false">5211138</guid>        </item>
        <item>
            <title>Classification of schizophrenia using feature-based morphometry</title>
            <link>http://www.medworm.com/index.php?rid=5211139&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkk55446413687132%2F</link>
            <description>The objective of this study was to use a combined local descriptor, namely scale invariance feature transform (SIFT), and
 a non linear support vector machine (SVM) technique to automatically classify patients with schizophrenia. The dorsolateral
 prefrontal cortex (DLPFC), considered a reliable neuroanatomical marker of the disease, was chosen as region of interest (ROI).
 Fifty-four schizophrenia patients and 54 age- and gender-matched normal controls were studied with a 1.5T MRI (slice thickness
 1.25&amp;nbsp;mm). Three steps were conducted: (1) landmark detection and description of the DLPFC, (2) feature vocabulary construction and Bag-of-Words (BoW) computation for brain representation, (3) SVM classification which adopted the local kernel to implicitly implement the feature matching. Mo...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211139</comments>
            <pubDate>Fri, 09 Sep 2011 05:45:25 +0100</pubDate>
            <guid isPermaLink="false">5211139</guid>        </item>
        <item>
            <title>Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice</title>
            <link>http://www.medworm.com/index.php?rid=5211141&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa53777m6v00v4505%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The neuromodulating tryptophan metabolite kynurenic acid (KYNA) is increased in the brain of patients with schizophrenia.
 In the present study we investigate the spontaneous locomotor activity as well as the locomotor response to d-amphetamine
 [5&amp;nbsp;mg/kg, administered intraperitoneal (i.p.)] after increasing endogenous levels of brain KYNA in mice by acute (10&amp;nbsp;mg/kg,
 i.p., 60&amp;nbsp;min) or subchronic (100&amp;nbsp;mg/kg i.p., twice daily for 6&amp;nbsp;days) pretreatment with the blood–brain crossing precursor,
 l-kynurenine. We found that an acute increase in the brain KYNA levels caused increased corner time and percent peripheral
 activity but did not change the d-amphetamine-induced locomotor response. In contrast, subchronic elevation of KYNA did not
 change th...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211141</comments>
            <pubDate>Fri, 09 Sep 2011 05:45:24 +0100</pubDate>
            <guid isPermaLink="false">5211141</guid>        </item>
        <item>
            <title>The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats</title>
            <link>http://www.medworm.com/index.php?rid=5211143&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F21j4j42738n71429%2F</link>
            <description>This study revealed the following results: (1) intrathecal administration
 of minocycline (a microglial activation inhibitor) could prevent mechanical allodynia during the initiation of SNL-induced
 neuropathic pain, and its action was associated with the elimination of BDNF overexpression in the dorsal horn; (2) the spinal
 injection of fluorocitrate (an astrocytic activation inhibitor) but not minocycline could reverse mechanical allodynia during
 the maintenance phase of SNL-induced pain, and its action was also related to a decrease in BDNF overexpression in the dorsal
 horn; and (3) treatment with TrkB/Fc (a BDNF-sequestering protein) had a similar effect during both the early development
 and maintenance periods. These results led to the following conclusions: (1) elevated BDNF expre...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211143</comments>
            <pubDate>Thu, 08 Sep 2011 05:56:53 +0100</pubDate>
            <guid isPermaLink="false">5211143</guid>        </item>
        <item>
            <title>The pedunculopontine nucleus: from basic neuroscience to translational applications for Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5211142&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa2532705760320w3%2F</link>
            <description>Content Type Journal ArticleCategory PrefacePages 1-2DOI 10.1007/s00702-011-0711-9

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211142</comments>
            <pubDate>Thu, 08 Sep 2011 05:56:53 +0100</pubDate>
            <guid isPermaLink="false">5211142</guid>        </item>
        <item>
            <title>Tau protein and beta-amyloid1-42 CSF levels in different phenotypes of Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5211144&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7m757281871vl3x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) is a neurodegenerative disorder with highly heterogeneous clinical manifestations. This fact has
 prompted many attempts to divide PD patients into clinical subgroups. This could lead to a better recognition of pathogenesis,
 improving targeted treatment and the prognosis of PD patients. The aim of the present study was to obtain cerebrospinal fluid
 (CSF) samples in PD patients and to search for a relationship between neurodegenerative CSF markers (tau protein, beta-amyloid1-42 and index tau protein/beta-amyloid1-42) and the clinical subtypes. PD patients were divided into three subgroups: early disease onset (EDO), tremor-dominant PD
 (TD-PD), and non-tremor dominant PD (NT-PD) according to the previously published classification. Neurodegen...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211144</comments>
            <pubDate>Sun, 04 Sep 2011 10:45:57 +0100</pubDate>
            <guid isPermaLink="false">5211144</guid>        </item>
        <item>
            <title>Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation</title>
            <link>http://www.medworm.com/index.php?rid=5185594&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw585717583128718%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A significant proportion of patients with Parkinson’s disease (PD) receiving dopamine replacement therapy in the form of levodopa
 develop dyskinesia that becomes a major complicating factor in treatment. Dyskinesia can only be effectively treated by a
 reduction in drug dose, which limits efficacy, by co-administration of the weak NMDA antagonist amantadine or by surgical
 treatment (pallidotomy, DBS). This raises the important question of why dyskinesia occurs in PD and how it can be avoided
 or suppressed by pharmacological treatment. This review assesses some of the mechanisms that underlie dyskinesia induction
 and expression from presynaptic changes in dopaminergic neurones to postsynaptic alterations in basal ganglia function and
 examines potential approaches ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185594</comments>
            <pubDate>Wed, 31 Aug 2011 15:54:33 +0100</pubDate>
            <guid isPermaLink="false">5185594</guid>        </item>
        <item>
            <title>Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression</title>
            <link>http://www.medworm.com/index.php?rid=5185593&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F65465340111h74m8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The treatment of the motor symptoms of Parkinson’s disease (PD) is dependent on the use of dopamine replacement therapy in
 the form of l-dopa and dopamine agonist drugs. However, the development of dyskinesia (chorea, dystonia, athetosis) can become treatment
 limiting. The initiation of dyskinesia involves a priming process dependent on the presence of nigral dopaminergic cell loss
 leading to alterations in basal ganglia function that underlie the expression of involuntary movements following the administration
 of each drug dose. Once established, dyskinesia is difficult to control and it is even more difficult to reverse the priming
 process. Dyskinesia is more commonly induced by l-dopa than by dopamine agonist drugs. This has been associated with the short dura...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185593</comments>
            <pubDate>Wed, 31 Aug 2011 15:54:33 +0100</pubDate>
            <guid isPermaLink="false">5185593</guid>        </item>
        <item>
            <title>Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients</title>
            <link>http://www.medworm.com/index.php?rid=5185595&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd325633103x6w208%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of the present study was to assess the origin of the substantia nigra hyperechogenicity in Parkinson disease patients.
 The cause of hyperechogenicity was tested on an animal model. Fresh porcine brains were injected consecutively with ferritin,
 apoferritin and water. Then, glioma samples were inserted into animal model. The echogenicity of the region of interest was
 assessed before and after experimental procedures. We observed the same echogenicity of porcine brain before and after injections
 of iron-loaded ferritin, apoferritin and water. Increased echogenicity of glioma samples compared to surrounding porcine brain
 tissue could be clearly seen. We postulate that the relative gliosis might be, at least partially, responsible for the increased
 echogenicit...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185595</comments>
            <pubDate>Wed, 31 Aug 2011 15:54:31 +0100</pubDate>
            <guid isPermaLink="false">5185595</guid>        </item>
        <item>
            <title>Association of cognitive performance with interleukin-6 receptor Asp358Ala polymorphism in healthy adults</title>
            <link>http://www.medworm.com/index.php?rid=5185596&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpv61874861532316%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Wechsler adult intelligence scale-revised was performed in 576 healthy adults to examine whether a functional polymorphism
 (Asp358Ala) of the IL-6 receptor (IL-6R) gene is associated with cognitive performance. Verbal intelligence quotient in Asp
 homozygotes was significantly higher compared to Ala carriers (P&amp;nbsp;=&amp;nbsp;0.005). Compared to Ala carriers, Asp homozygotes performed better in the verbal subtests requiring long-term memory stores.
 Elevated IL-6 and soluble IL-6R levels in Ala carriers may have negative impact on acquiring verbal cognitive ability requiring
 long-term memory.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Short communicationPages 1-6DOI 10.1007/s00702-011-0709-3Authors
		Daimei Sasayama, Departme...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5185596</comments>
            <pubDate>Tue, 30 Aug 2011 15:56:34 +0100</pubDate>
            <guid isPermaLink="false">5185596</guid>        </item>
        <item>
            <title>Pilot study on HTR2A promoter polymorphism, −1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive–compulsive disorder</title>
            <link>http://www.medworm.com/index.php?rid=5176522&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft0573061x25m4453%2F</link>
            <description>In this study, we reanalyzed the association of this SNP with OCD in an enlarged
 population of 136 cases (55 previous&amp;nbsp;+&amp;nbsp;81 new cases) and compared them to 106 newly recruited, healthy, age-matched controls.
 We also investigated whether this SNP or its copy number variations (CNV) was associated with OCD severity and age of onset.
 The CNV was analyzed in a DNA region located near rs6311. The results confirmed the association between the A-allele and early
 onset OCD in children and adolescents, with an odds ratio (OR) of 1.69 [95% CI (1.17, 2.46); p&amp;nbsp;=&amp;nbsp;0.005]. Strikingly, we found that carriers of one copy (deletion) of the CNV were associated with a very early onset OCD
 (2.5&amp;nbsp;years earlier than the typical onset), and they had increased CY-BOCS scores (8.7 points...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5176522</comments>
            <pubDate>Sat, 27 Aug 2011 15:48:52 +0100</pubDate>
            <guid isPermaLink="false">5176522</guid>        </item>
        <item>
            <title>I. In vivo evidence for partial agonist effects of (−)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors</title>
            <link>http://www.medworm.com/index.php?rid=5176523&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj8q2ttv577304274%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The locomotor effects of (−)- and (+)-OSU6162 were evaluated in ‘low activity’ animals (reserpinized mice and habituated rats)
 and ‘high activity’ animals (drug-naive mice and non-habituated rats). Both enantiomers of OSU6162 had dual effects on behavior,
 stimulating locomotor activity in ‘low activity’ animals and inhibiting locomotor activity in ‘high activity’ animals. There
 were also certain differences between the two enantiomers in their behavioral profiles. The stimulatory effects of both enantiomers
 in reserpinized mice were blocked by the 5-HT2A selective antagonist M100907, but not by the D2-selective antagonists haloperidol
 or raclopride, or by the D1-selective antagonists SCH23390 or SCH39166. The stimulatory effect in mice was more pr...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5176523</comments>
            <pubDate>Sat, 27 Aug 2011 15:48:51 +0100</pubDate>
            <guid isPermaLink="false">5176523</guid>        </item>
        <item>
            <title>II. In vitro evidence that (−)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors</title>
            <link>http://www.medworm.com/index.php?rid=5164391&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn75124m72116k167%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;(−)-OSU6162 has promise for treating Parkinson’s disease, Huntington’s disease and schizophrenia. Behavioral tests evaluating
 the locomotor effects of (−) and (+)-OSU6162 on ‘low activity’ animals (reserpinized mice and habituated rats) and ‘high activity’
 animals (drug naive mice and non-habituated rats) revealed that both enantiomers of OSU6162 had dual effects on behavior,
 stimulating locomotor activity in ‘low activity’ animals and inhibiting locomotor activity in ‘high activity’ animals. To
 elucidate a plausible mechanism of action for their behavioral effects, we evaluated the intrinsic actions of (−)- and (+)-OSU6162,
 and a collection of other antipsychotic and antiparkinsonian agents at 5-HT2A and D2 receptors in functional assays ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164391</comments>
            <pubDate>Wed, 24 Aug 2011 16:05:42 +0100</pubDate>
            <guid isPermaLink="false">5164391</guid>        </item>
        <item>
            <title>AD: Are we intervening too late?</title>
            <link>http://www.medworm.com/index.php?rid=5164392&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft23387473t355856%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1359-1359DOI 10.1007/s00702-011-0702-xAuthors
		Amos D. Korczyn, The Sieratzki Chair of Neurology, Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, 69978 Tel-Aviv, Israel
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564
	
		Journal Volume Volume 118
	
		Journal Issue Volume 118, Number 9 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164392</comments>
            <pubDate>Tue, 23 Aug 2011 15:53:29 +0100</pubDate>
            <guid isPermaLink="false">5164392</guid>        </item>
        <item>
            <title>The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures</title>
            <link>http://www.medworm.com/index.php?rid=5164393&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj4xh46735k5j3864%2F</link>
            <description>In conclusion, these new results suggest a modulatory influence of KYNA on the process of epileptogenesis, characterized by
 a negative relationship between the KYNA and glutamate systems in the amygdala.
 
 
	Content Type Journal ArticleCategory Basic Neurosciences, Genetics and Immunology - Original ArticlePages 1-9DOI 10.1007/s00702-011-0700-zAuthors
		J. Szyndler, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 26/28 Krakowskie Przedmieście Street, 00-927 Warsaw, PolandP. Maciejak, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 26/28 Krakowskie Przedmieście Street, 00-927 Warsaw, PolandD. Turzyńska, Department of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957 Warsaw, PolandA...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164393</comments>
            <pubDate>Tue, 23 Aug 2011 05:56:39 +0100</pubDate>
            <guid isPermaLink="false">5164393</guid>        </item>
        <item>
            <title>Kynurenines in Parkinson’s disease: therapeutic perspectives</title>
            <link>http://www.medworm.com/index.php?rid=5147707&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F36k2411659266126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) is a chronic progressive neurodegenerative disorder the pathomechanism of which is not yet fully
 known. With regard to the molecular mechanism of development of the disease, oxidative stress/mitochondrial impairment, glutamate
 excitotoxicity and neuroinflammation are certainly involved. Alterations in the kynurenine pathway, the main pathway of the
 tryptophan metabolism, can contribute to the complex pathomechanism. There are several possibilities for therapeutic intervention
 involving targeting of this altered metabolic route. The development of synthetic molecules that would shift the altered balance
 towards the achievement of neuroprotective effects would be of great promise for future clinical studies on PD.
 
 
	Content Type Journal ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5147707</comments>
            <pubDate>Fri, 19 Aug 2011 15:57:59 +0100</pubDate>
            <guid isPermaLink="false">5147707</guid>        </item>
        <item>
            <title>Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats</title>
            <link>http://www.medworm.com/index.php?rid=5147708&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa27028k874722402%2F</link>
            <description>In this study methamphetamine (m-AMPH) and dextroamphetamine (d-AMPH) were compared to determine the potency of the two drugs
 on behavior and oxidative damage in brain of rats. Male adult Wistar rats were given single (acute administration) or repeated
 (chronic administration, 14&amp;nbsp;days) intraperitoneal injections of saline (0.9% NaCl), d-AMPH (2&amp;nbsp;mg/kg) or m-AMPH (0.25, 0.5,
 1 or 2&amp;nbsp;mg/kg). Locomotor activity was evaluated in open-field apparatus 2&amp;nbsp;h after the last drug injection. Additionally, thiobarbituric
 acid reactive substances (TBARS) and protein carbonyl formation were measured in the prefrontal cortex, amygdala, hippocampus
 and striatum. In both experiments, d-AMPH and m-AMPH (all doses administered) increased the locomotor activity of animals,
 meantime, no ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5147708</comments>
            <pubDate>Fri, 19 Aug 2011 15:57:58 +0100</pubDate>
            <guid isPermaLink="false">5147708</guid>        </item>
        <item>
            <title>Rescue of social behavior impairment by clozapine and alterations in the expression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade</title>
            <link>http://www.medworm.com/index.php?rid=5147709&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6779815u8530l362%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We have previously shown that pharmacological blockade of the gastrin-releasing peptide receptor (GRPR) during the neonatal
 period in rats produces behavioral features of developmental neuropsychiatric disorders. Here, we show that social interaction
 deficits in this model are reversed by the atypical antipsychotic clozapine given in the adulthood. In addition, we analyzed
 the mRNA expression of three neuronal receptors potentially involved in the etiology of disorders of the autism spectrum.
 Rats were injected with the GRPR antagonist RC-3095 or saline (SAL) from postnatal days 1–10, and tested for social behavior
 and recognition memory in the adulthood. One hour prior to the behavioral testing, rats were given a systemic injection of
 clozapine or saline. The m...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5147709</comments>
            <pubDate>Wed, 17 Aug 2011 05:55:16 +0100</pubDate>
            <guid isPermaLink="false">5147709</guid>        </item>
        <item>
            <title>Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro</title>
            <link>http://www.medworm.com/index.php?rid=5133705&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07966g236q2q1535%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several lines of evidence indicate that excess iron may play an etiologically significant role in neurodegenerative disorders.
 This idea is supported, for example, by experimental studies in animals demonstrating significant neuroprotection by iron
 chelation. Here, we tested whether this effect might be related to a functional link between iron and the endogenous excitotoxin
 quinolinic acid (QUIN), a presumed pathogen in several neurological disorders. In particular, the present in vitro study was
 designed to examine the effects of Fe2+, a known co-factor of oxygenases, on the activity of QUIN’s immediate biosynthetic enzyme, 3-hydroxyanthranilic acid dioxygenase
 (3HAO), in the brain. In crude tissue homogenate, addition of Fe2+ (2–40&amp;nbsp;μM) stimulated 3HAO ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5133705</comments>
            <pubDate>Thu, 11 Aug 2011 05:54:09 +0100</pubDate>
            <guid isPermaLink="false">5133705</guid>        </item>
        <item>
            <title>A 14 bp indel variation in the NCX1 gene modulates the age at onset in late-onset Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5133706&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76154n3726120372%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Calcium homeostasis is critical to amyloid beta precursor protein (APP) processing. Na+/Ca2+ exchanger (NCX) proteins play an important role in maintaining intracellular Na+ and Ca2+ homeostasis in the brain under physiological and pathological conditions. We sequenced a hyper-variable region in intron
 2 of the Na+/Ca2+ exchanger 1 gene (NCX1), and investigated whether insertion/deletion variations in this region are associated with the occurrence for Alzheimer’s
 disease (AD). Examining 413 AD patients and 361 healthy controls, we identified 3 insertion/deletion polymorphisms. No significant
 differences of the allele and genotype frequencies were observed between the AD cases and the controls for any of the three
 polymorphisms. However, among the AD patients whose...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5133706</comments>
            <pubDate>Thu, 11 Aug 2011 05:54:08 +0100</pubDate>
            <guid isPermaLink="false">5133706</guid>        </item>
        <item>
            <title>Behavioural studies with a newly developed neuroprotective KYNA-amide</title>
            <link>http://www.medworm.com/index.php?rid=5104120&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe7lkr3225060325v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The neuroactive properties and neuroprotective potential of endogenous l-kynurenine, kynurenic acid (KYNA) and its derivatives are well established. KYNA acts as an antagonist on the obligatory
 co-agonist glycine site, and has long been at the focus of neuroprotective trials. Unfortunately, KYNA is barely able to cross
 the blood–brain barrier. Accordingly, the development and synthesis of KYNA analogs which can readily cross the BBB have been
 at the focus of research interest with the aim of neuroprotection. Earlier we reported a new KYNA-amide crosses the BBB and
 proved neuroprotective in several experiments. In the present study, we investigated the locomotor activity, working memory
 performance, and also the long-lasting, consolidated reference memory of anima...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5104120</comments>
            <pubDate>Fri, 05 Aug 2011 05:58:32 +0100</pubDate>
            <guid isPermaLink="false">5104120</guid>        </item>
        <item>
            <title>Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID)</title>
            <link>http://www.medworm.com/index.php?rid=5081434&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1j2k312463k12up7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neuronal intermediate filament inclusion disease (NIFID), a rare form of frontotemporal lobar degeneration (FTLD), is characterized
 neuropathologically by focal atrophy of the frontal and temporal lobes, neuronal loss, gliosis, and neuronal cytoplasmic inclusions
 (NCI) containing epitopes of ubiquitin and neuronal intermediate filament (IF) proteins. Recently, the ‘fused in sarcoma’
 (FUS) protein (encoded by the FUS gene) has been shown to be a component of the inclusions of NIFID. To further characterize FUS proteinopathy in NIFID, we
 studied the spatial patterns of the FUS-immunoreactive NCI in frontal and temporal cortex of 10 cases. In the cerebral cortex,
 sectors CA1/2 of the hippocampus, and the dentate gyrus (DG), the FUS-immunoreactive NCI were frequent...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5081434</comments>
            <pubDate>Tue, 26 Jul 2011 15:58:19 +0100</pubDate>
            <guid isPermaLink="false">5081434</guid>        </item>
        <item>
            <title>Malnutritional neuropathy under intestinal levodopa infusion</title>
            <link>http://www.medworm.com/index.php?rid=5064914&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpg052h81v435r445%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Levodopa/Carbidopa intestinal gel infusion (LCIG) for Parkinson’s disease is under debate to provoke polyneuropathy (PNP).
 In our cohort of 20 thus treated patients, two developed debilitating axonal PNP with deficient pyridoxin and folate levels,
 and marginal cobalamin. Homocysteine was highly elevated. The neuropathies responded to vitamin replacement. We assume that
 LCIG can provoke PNP most likely of malnutritional origin. To avoid this side effect, the assessment of predisposing factors
 before treatment as well as neurophysiological and laboratory screenings appear necessary.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s00702-011-0689-3Authors
		Fabian Klostermann, Deptartment of Neurology, CBF, Charité-University Medicine Berlin, Hindenburdamm 30,...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064914</comments>
            <pubDate>Sat, 23 Jul 2011 15:44:26 +0100</pubDate>
            <guid isPermaLink="false">5064914</guid>        </item>
        <item>
            <title>The possible role of the kynurenine pathway in anhedonia in adolescents</title>
            <link>http://www.medworm.com/index.php?rid=5064916&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F660068345l564534%2F</link>
            <description>In conclusions, our findings provide further support for the role for the KP, particularly IDO, in anhedonia in
 adolescent MDD. These results emphasize the importance of dimensional approaches in the investigation of psychiatric disorders.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s00702-011-0685-7Authors
		Vilma Gabbay, Department of Child and Adolescent Psychiatry, NYU Child Study Center, NYU School of Medicine, New York University Langone Medical Center, 577 First Avenue, New York, NY 10016, USABenjamin A. Ely, Department of Child and Adolescent Psychiatry, NYU Child Study Center, NYU School of Medicine, New York University Langone Medical Center, 577 First Avenue, New York, NY 10016, USAJames Babb, Radiology, Research, NYU School of Medicine, Bellevue C&amp;D Building 122, 462...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064916</comments>
            <pubDate>Sat, 23 Jul 2011 15:44:25 +0100</pubDate>
            <guid isPermaLink="false">5064916</guid>        </item>
        <item>
            <title>Comment: should we diagnose MCI in Parkinson disease?</title>
            <link>http://www.medworm.com/index.php?rid=5064915&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxh58374575750037%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00702-011-0687-5Authors
		Amos D. Korczyn, The Sieratzki Chair of Neurology, Sackler School of Medicine, Tel-Aviv University, 69978 Ramat-Aviv, Israel
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064915</comments>
            <pubDate>Sat, 23 Jul 2011 15:44:25 +0100</pubDate>
            <guid isPermaLink="false">5064915</guid>        </item>
        <item>
            <title>Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells</title>
            <link>http://www.medworm.com/index.php?rid=5064917&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx5815vu4512r6w21%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Histone deacetylase inhibitors are promising anti-tumor agents partly due to their ability to disrupt the hypoxic signaling
 pathway in human malignancies. However, little is known about any effects of these drugs on the central nervous system. The
 aim of the present study was to analyze the effects of trichostatin A (TSA)—a broad-spectrum histone deacetylase inhibitor—on
 the transcriptional regulation of several genes involved in dopamine- and serotonergic neurotransmission. To this end, short-term
 parallel cultures of SK-NF-I neuroblastoma cells were treated with TSA either alone or in combination with hypoxia, and mRNA
 levels of dopamine receptor D3 (DRD3) and D4 (DRD4), dopamine transporter (DAT), dopamine hydroxylase (DBH), dopamine receptor
 regulating fac...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064917</comments>
            <pubDate>Fri, 22 Jul 2011 17:05:12 +0100</pubDate>
            <guid isPermaLink="false">5064917</guid>        </item>
        <item>
            <title>Serum nitric oxide concentrations in patients with multiple sclerosis and patients with epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=5064918&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc1q1k5771774n720%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nitric oxide (NO), a neurotransmitter and a free radical, has been purported to be involved in numerous neurological diseases.
 We investigated the serum nitric oxide concentration in 30 patients with multiple sclerosis (MS), in 30 patients with epilepsy
 and in 30 control subjects. The aim was also to determine whether a statistically significant difference in serum NO concentrations
 exists between the groups of interest. The total serum nitric oxide concentration was measured using the Griess reaction after
 reducing nitrates to nitrites with elemental zinc. In the group multiple sclerosis, the mean NO concentrations were X&amp;nbsp;±&amp;nbsp;SEM&amp;nbsp;=&amp;nbsp;31.02&amp;nbsp;±&amp;nbsp;1.79&amp;nbsp;μmol/l, in the control group X&amp;nbsp;±&amp;nbsp;SEM&amp;nbsp;=&amp;nbsp;25.31&amp;nbsp;±&amp;nbsp;1.44&amp;nb...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064918</comments>
            <pubDate>Thu, 21 Jul 2011 18:04:39 +0100</pubDate>
            <guid isPermaLink="false">5064918</guid>        </item>
        <item>
            <title>Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson’s disease?</title>
            <link>http://www.medworm.com/index.php?rid=5064919&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe4n4745181vx786v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;EWO (Epidemiology of Wearing-Off symptoms among the population of Parkinson’s disease (PD) patients on L-DOPA) is a multicentric,
 non-interventional, epidemiological and exploratory trial, focused on patients with PD who are treated with L-DOPA. The primary
 objective is the estimation of wearing-off symptoms (based on WOQ-9 questionnaire and assessment by neurologists) among PD
 patients who are treated with L-DOPA. From September 30, 2007 to June 30, 2008 altogether 563 valid records of PD patients
 were collected in movement disorders centers (Level A and Level B centers). Wearing-off symptoms were observed in 66.7% of
 PD patients (neurologists’ assessment) and in 90.6% of PD patients (WOQ-9 questionnaire). The biggest discrepancy was found
 in PD patients trea...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064919</comments>
            <pubDate>Tue, 19 Jul 2011 06:40:06 +0100</pubDate>
            <guid isPermaLink="false">5064919</guid>        </item>
        <item>
            <title>Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics</title>
            <link>http://www.medworm.com/index.php?rid=5041738&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F23815t735q55w570%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Reliable biomarkers that can be used for early diagnosis and tracking disease progression are the cornerstone of the development
 of disease-modifying treatments for Parkinson’s disease (PD). The German Society of Experimental and Clinical Neurotherapeutics
 (GESENT) has convened a Working Group to review the current status of proposed biomarkers of neurodegeneration according to
 the following criteria and to develop a consensus statement on biomarker candidates for evaluation of disease-modifying therapeutics
 in PD. The criteria proposed are that the biomarker should be linked to fundamental features of PD neuropathology and mechanisms
 underlying neurodegeneration in PD, should be correlated to disease progression assessed by clinical rating scales, should
 monito...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5041738</comments>
            <pubDate>Thu, 14 Jul 2011 06:01:13 +0100</pubDate>
            <guid isPermaLink="false">5041738</guid>        </item>
        <item>
            <title>Editorial comments</title>
            <link>http://www.medworm.com/index.php?rid=5041739&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9048u047803u0760%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00702-011-0677-7Authors
		Natan M. Bornstein, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5041739</comments>
            <pubDate>Thu, 14 Jul 2011 06:01:12 +0100</pubDate>
            <guid isPermaLink="false">5041739</guid>        </item>
        <item>
            <title>Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy</title>
            <link>http://www.medworm.com/index.php?rid=5031876&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh8773347760q8mg3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Angiogenesis has not been extensively studied in Parkinson’s disease (PD) despite being associated with other neurodegenerative
 disorders. Post-mortem human brain tissues were obtained from subjects with pathologically confirmed Parkinson’s disease (PD)
 and progressive supranuclear palsy (PSP), a rapidly progressing Parkinsonian-like disorder. Tissues were also obtained from
 subjects with incidental Lewy body disease (iLBD) who had Lewy bodies in the substantia nigra pars compacta (SNpc) but had not been diagnosed with PD, and age-matched controls without Lewy body pathology. The SNpc, putamen, locus ceruleus
 (LC) and midfrontal cortex were examined for integrin αvβ3, a marker for angiogenesis, along with vessel number and activated
 microglia. All parkinsonia...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5031876</comments>
            <pubDate>Tue, 12 Jul 2011 05:57:31 +0100</pubDate>
            <guid isPermaLink="false">5031876</guid>        </item>
        <item>
            <title>The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer’s disease in rats</title>
            <link>http://www.medworm.com/index.php?rid=5022573&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3v50417923871100%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Astrocytes play a fundamental role in glutamate metabolism by regulating the extracellular levels of glutamate and intracellular
 levels of glutamine. They also participate in antioxidant defenses, due to the synthesis of glutathione, coupled to glutamate
 metabolism. Although the cause of Alzheimer’s disease (AD) remains elusive, some changes in neurochemical parameters, such
 as glutamate uptake, glutamine synthetase activity and glutathione have been investigated in this disease. A possible neuroprotective
 effect of two statins, simvastatin and pravastatin (administered p.o.), was evaluated using a model of dementia, based on
 the intracerebroventricular (ICV) administration of streptozotocin (STZ), and astrocyte parameters were determined. We confirmed
 a cogniti...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5022573</comments>
            <pubDate>Sun, 10 Jul 2011 05:51:45 +0100</pubDate>
            <guid isPermaLink="false">5022573</guid>        </item>
        <item>
            <title>The kynurenine system and immunoregulation</title>
            <link>http://www.medworm.com/index.php?rid=5022574&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm7n17350gx63q3j0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is developing interest in the role of the kynurenines in the immune function. A considerable amount of evidence has
 accumulated as concerns interactions between the kynurenine pathway, cytokines and the nervous system. Indoleamine 2,3-dioxygenase
 (IDO) occupies a key position connecting the immune system and the kynurenine pathway. There are evidences of the immunosuppressive
 effect of IDO. Following the interferon (IFN)-mediated activation of antigen presenting cells, the induction of IDO and the
 kynurenine system exerts a counter-regulating effect, maintaining the homeostasis. Inhibition of T cell functions, activation
 of the regulatory T cells, and the inhibition of Natural Killer cells are among the important factors in the immunosuppressive
 effects of I...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5022574</comments>
            <pubDate>Sat, 09 Jul 2011 06:16:46 +0100</pubDate>
            <guid isPermaLink="false">5022574</guid>        </item>
        <item>
            <title>Negative argument for debate with V. O. Emery for J Neural Transmission</title>
            <link>http://www.medworm.com/index.php?rid=5022575&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj822315357586171%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alzheimer’s disease (AD) represents a major public health challenge. It is the most common cause of dementia, the worldwide
 prevalence of which will double every 20&amp;nbsp;years in the foreseeable future. It would be good if it were possible to treat AD
 early to diminish its impact, but current evidence does not support early intervention. Vitamin E was no more effective than
 placebo in a study of vitamin E and donepezil against placebo in mild cognitive impairment (MCI). Vitamin E is associated
 with a higher rate of haemorrhagic events than is placebo. Neither donepezil nor galantamine has been shown to be helpful
 in retarding progression from MCI to AD. Gingko biloba was ineffective in delaying the onset of AD in a large prospective
 trial involving over 6,000 pa...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5022575</comments>
            <pubDate>Fri, 08 Jul 2011 06:29:06 +0100</pubDate>
            <guid isPermaLink="false">5022575</guid>        </item>
        <item>
            <title>Dream features in the early stages of Parkinson’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=4987510&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5l845v13x1651312%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Few studies have investigated the relation between dream features and cognition in Parkinson’s disease (PD), although vivid
 dreams, hallucinations and cognitive decline have been proposed as successive steps of a pathological continuum. Our objectives
 were therefore to characterize the dreams of early stage PD and to study the relation between dream characteristics, cognitive
 function, motor status, depression, dopaminergic treatment, and the presence of REM sleep behaviour disorder (RBD) and hallucinations.
 Dreams of 19 male PD patients and 21 matched control subjects were classified according to Hall and van de Castle system.
 h statistics was used to compare the dream content between patients and controls. We tested the relation between patients’
 dreams char...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987510</comments>
            <pubDate>Wed, 29 Jun 2011 15:51:59 +0100</pubDate>
            <guid isPermaLink="false">4987510</guid>        </item>
        <item>
            <title>Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism</title>
            <link>http://www.medworm.com/index.php?rid=4971592&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd250114wp6u33210%2F</link>
            <description>This study describes
 ten patients with parkinsonism and symptoms of dyspnea and respiratory distress that were unexplained by a pulmonary or cardiac
 abnormality or a psychological problem. Suggested underlying mechanisms are a central pathology affecting respiratory rhythm
 generation at the brainstem or lack of coordination of the respiratory muscles causing involuntary movements of the diaphragm.
 Dyspnea and respiratory distress should be included among the non-motor symptoms of parkinsonism.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s00702-011-0671-0Authors
		Shlomit Yust-Katz, Department of Neurology, Movement Disorders Clinic, Rabin Medical Center, 49100 Petach Tikva, IsraelDavid Shitrit, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelEldad Melamed, D...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971592</comments>
            <pubDate>Sat, 25 Jun 2011 15:53:58 +0100</pubDate>
            <guid isPermaLink="false">4971592</guid>        </item>
        <item>
            <title>Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage</title>
            <link>http://www.medworm.com/index.php?rid=4971593&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx3n23l4145v85371%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several components of the kynurenine pathway of tryptophan metabolism are now recognised to have actions of profound biological
 importance. These include the ability to modulate the activation of glutamate and nicotinic receptors, to modify the responsiveness
 of the immune system to inflammation and infection, and to modify the generation and removal of reactive oxygen species. As
 each of these factors is being recognised increasingly as contributing to major disorders of the central nervous system (CNS),
 so the potentially fundamental role of the kynurenine pathway in those disorders is presenting a valuable target both for
 understanding the progress of those disorders and for developing potential drug treatments. This review will summarise some
 of the evidence f...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971593</comments>
            <pubDate>Tue, 21 Jun 2011 20:55:33 +0100</pubDate>
            <guid isPermaLink="false">4971593</guid>        </item>
        <item>
            <title>Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism?</title>
            <link>http://www.medworm.com/index.php?rid=4971594&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn17r501t7177pv30%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Stimulation of the subthalamic nucleus (STN) improves the cardinal features of Parkinson disease (PD). However, its efficacy
 on gait disorders is less satisfying in the long term. In recent years, the pedunculopontine (PPN) nucleus has emerged as
 a possible promising deep brain stimulation target for gait disorders in PD. In this review, we examine whether STN and PPN
 act synergistically or antagonistically. Results suggest that the combination of STN and PPN stimulations leads to a significant
 further improvement in gait as compared with STN stimulation alone, but additive effects on the classical motor triad are
 questionable. Thus, they highlight the specificity of STN stimulation over PPN’s for the PD cardinal features and the specificity
 of PPN stimulation o...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971594</comments>
            <pubDate>Tue, 21 Jun 2011 20:55:32 +0100</pubDate>
            <guid isPermaLink="false">4971594</guid>        </item>
        <item>
            <title>Is all cognitive impairment in Parkinson’s disease “mild cognitive impairment”?</title>
            <link>http://www.medworm.com/index.php?rid=4971595&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61734634mqj53451%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cognitive impairment can be demonstrated in Parkinson’s disease (PD) from the very beginning of the disease. Clinical manifestations
 range from slight deficits, only demonstrable by means of neuropsychological testing, up to dementia. If a linear involution
 is supposed for the cognitive worsening in PD, then the relatively subtle cognitive defects should be taken as the earliest
 signs of dementia implying that PD-MCI concept would be thoroughly equivalent to that used for the early prediction of other
 dementias among healthy population. Cognitive defects in PD, however, may not follow a normal distribution. While fronto-striatal
 deficits, such as working memory, set-shifting and free-recall verbal memory appear altered in most patients during long periods
 of tim...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971595</comments>
            <pubDate>Tue, 21 Jun 2011 20:55:31 +0100</pubDate>
            <guid isPermaLink="false">4971595</guid>        </item>
        <item>
            <title>Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder</title>
            <link>http://www.medworm.com/index.php?rid=4971597&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn0711r455v242164%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Studies examining intermediate phenotypes such as neurocognitive and neuroanatomical measures along with susceptibility genes
 are important for improving our understanding of the neural basis of schizophrenia (SZ) and bipolar disorder (BD). In this
 paper, we review extant studies involving neurocognitive-genetic and neuroimaging-genetic perspectives and particularly related
 to catechol-O-methyltransferase (COMT), brain-derived neurotrophic factor (BDNF) and neuregulin-1 (NRG1) genes in SZ and BD. In terms of neurocognitive-genetic investigations, COMT and BDNF are the two most studied candidate genes especially in patients with SZ. Whereas BDNF Met carriers perform worse on verbal working memory, problem solving and visuo-spatial abilities, COMT Met carriers perform ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971597</comments>
            <pubDate>Tue, 21 Jun 2011 17:59:31 +0100</pubDate>
            <guid isPermaLink="false">4971597</guid>        </item>
        <item>
            <title>Mild cognitive impairment exists in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4971596&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn0q4567275h16132%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cognitive impairment exists in Parkinson’s disease (PD) as a transitional state between cognitively intact and demented PD
 patients. It seems to be a risk factor for the development of dementia in PD, but the precise criteria and unfavorable cognitive
 profile of mild cognitive impairment in PD (MCI-PD) have not yet been established. The concept may turn to be different from
 that in Alzheimer’s disease since we search for those already diagnosed PD patients who are at risk of developing dementia.
 In addition, clinical variables specific for PD also play role. Importantly, MCI possesses a metabolic basis in PD. Various
 biomarkers particularly including neuropsychological testing and the brain imaging hold promise in identification of MCI-PD
 patients with unfavor...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971596</comments>
            <pubDate>Tue, 21 Jun 2011 17:59:31 +0100</pubDate>
            <guid isPermaLink="false">4971596</guid>        </item>
        <item>
            <title>Erratum to: Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease</title>
            <link>http://www.medworm.com/index.php?rid=4947394&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu115p7n5403v6367%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00702-011-0669-7Authors
		Brit Mollenhauer, Paracelsus-Elena Klinik, Kassel and Georg-August University, Göttingen, GermanyHermann Esselmann, Department of Psychiatry, Rheinische Kliniken Essen, University of Duisburg-Essen, Essen, GermanySigrun Roeber, Department of Neuropathology, Ludwig Maximilians University, Munich, GermanyWalter J. Schulz-Schaeffer, Department of Neuropathology, University Medical Center, Göttingen, GermanyClaudia Trenkwalder, Paracelsus-Elena Klinik, Kassel and Georg-August University, Göttingen, GermanyMirko Bibl, Kliniken Essen Mitte, Department of Psychiatry, Psychotherapy and addiction medicine, University of Duisburg-Essen, Henricistrasse 92, 45136 Essen, GermanyPetra Steinacker, Department of Neurology, Un...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947394</comments>
            <pubDate>Wed, 15 Jun 2011 05:52:22 +0100</pubDate>
            <guid isPermaLink="false">4947394</guid>        </item>
        <item>
            <title>Special Issue: Amine oxidases: structures, mechanisms and therapeutic targets</title>
            <link>http://www.medworm.com/index.php?rid=4939741&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F516g704u81030124%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00702-011-0670-1Authors
		Andrew Holt, Edmonton, CanadaDarrell D. Mousseau, Saskatoon, CanadaGlen B. Baker, Edmonton, Canada
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4939741</comments>
            <pubDate>Sun, 12 Jun 2011 06:02:45 +0100</pubDate>
            <guid isPermaLink="false">4939741</guid>        </item>
        <item>
            <title>New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio</title>
            <link>http://www.medworm.com/index.php?rid=4939742&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn31m1384x8240327%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Altered function of kynurenine pathway has emerged recently as one of the factors contributing to the pathogenesis of depression.
 Neuroprotective kynurenic acid (KYNA) and neurotoxic 3-hydroxykynurenine (3-HK) are two immediate metabolites of l-kynurenine. Here, we aimed to assess the hypothesis that antidepressant drugs that may change brain KYNA/3-HK ratio. In primary
 astroglial cultures, fluoxetine, citalopram, amitriptyline and imipramine (1–10&amp;nbsp;μM) increased de novo production of KYNA and
 diminished 3-HK synthesis (24 and 48, but not 2&amp;nbsp;h). RT-PCR studies revealed that Kat1, Kat2 and kynurenine-3-monooxygenase (Kmo) gene expressions were not altered after 2&amp;nbsp;h. At 24&amp;nbsp;h, the expression of Kat1 and Kat2 genes was enhanced by all studied drugs, ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4939742</comments>
            <pubDate>Fri, 10 Jun 2011 06:27:04 +0100</pubDate>
            <guid isPermaLink="false">4939742</guid>        </item>
        <item>
            <title>Alzheimer disease: are we intervening too late?</title>
            <link>http://www.medworm.com/index.php?rid=4915481&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F10235033497l0m82%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The affirmative position is argued in response to the question of whether intervention in the disease course of Alzheimer
 disease (AD) occurs too late. AD is not a singular, homogeneous disease, but rather a final common pathway or end-point that
 can be arrived at through multiple routes. As part of the affirmative argument, there is a delineation of two long-term trajectories
 leading to AD: (1) normal elderly progression to AD, and (2) depressed elderly progression to AD. In documenting normal elderly
 devolution into AD, two “normal” elderly pre-AD or prodromal stages are discussed: age-associated memory impairment (AAMI)
 and mild cognitive impairment (MCI). Data are provided evidencing significantly high conversion rates from these pre-AD stages
 to actual AD...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915481</comments>
            <pubDate>Mon, 06 Jun 2011 15:00:20 +0100</pubDate>
            <guid isPermaLink="false">4915481</guid>        </item>
        <item>
            <title>The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal model</title>
            <link>http://www.medworm.com/index.php?rid=4915482&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk2mt0461g07mp626%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Selegiline is a selective irreversible inhibitor of the B-type of monoamine oxidase (MAO-B). The spectrum of its pharmacological
 activity is wide, possesses antioxidant, antiapoptotic and neuroprotective properties and, additionally, we found it is effective
 on the total scavenger capacity (TSC), and the regulation of fat content in rat liver kept on lipid-rich diet. Our aim was
 to clarify whether the oral treatment with selegiline is protective on oxidative damage of Sprague–Dawley adult rats in vivo.
 Four groups of rats (five animals in a group) were examined: (1) lipid-rich diet, (2) normal rat food, (3) lipid-rich diet&amp;nbsp;+&amp;nbsp;selegiline
 and (4) normal rat food&amp;nbsp;+&amp;nbsp;selegiline. Selegiline solution (2.5&amp;nbsp;µg/ml) was supplied with the drinking wa...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915482</comments>
            <pubDate>Sun, 05 Jun 2011 05:45:09 +0100</pubDate>
            <guid isPermaLink="false">4915482</guid>        </item>
        <item>
            <title>Kynurenines and headache</title>
            <link>http://www.medworm.com/index.php?rid=4915483&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fanhn04l4732h5420%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In parallel to serotonin synthesis, the major route of tryptophan catabolism is the kynurenine pathway, which produces neuroactive
 metabolites. Among these substances, kynurenic acid has potential neuroprotective action blocking glutamate release and glutamatergic
 neurotransmission. Glutamate is a key player in migraine pathogenesis; it is crucial in the communication of first and second-order
 neurons, and it has an important role in the genesis of cortical spreading depression, which is the electrophysiological correlate
 for migraine aura and may be involved in the activation of the trigeminal system. Thus, kynurenines may affect the pathogenesis
 directly, by acting on glutamate receptors and exerting other neuromodulatory effects, and indirectly via an altered se...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915483</comments>
            <pubDate>Sat, 04 Jun 2011 05:52:17 +0100</pubDate>
            <guid isPermaLink="false">4915483</guid>        </item>
        <item>
            <title>The role of memory-related gene polymorphisms, KIBRA and CLSTN2, on replicate memory assessment in the elderly</title>
            <link>http://www.medworm.com/index.php?rid=4915484&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhn302764m3831010%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The role of the CLSTN2 (rs6439886) and KIBRA (rs17070145) SNPs in cognitive impairment was analysed in a 75–76&amp;nbsp;years old group.
 Various memory assessment tests were carried out on individuals at baseline and during follow-up investigations, and biallelic
 genotyping was performed. No influence of the allele status of either SNPs was observed on any memory test. No increased risk
 of any type of late development, and cognitive impairment was associated with rs6439886 or rs17070145.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s00702-011-0667-9Authors
		N. Sédille-Mostafaie, Department of Clinical Chemistry and Laboratory Medicine, Danube Hospital, Langobardenstr. 122, 1220 Vienna, AustriaC. Sebesta, Department of Internal Medicine, Danube Hospital, Vien...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915484</comments>
            <pubDate>Sat, 04 Jun 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">4915484</guid>        </item>
        <item>
            <title>An improved approach to steady-state analysis of monoamine oxidases</title>
            <link>http://www.medworm.com/index.php?rid=4915485&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F123q73v321r34553%2F</link>
            <description>In this study, we present evidence that monoamine oxidase activity is often not adequately
 described by this approach. We outline a novel equation strategy that takes account of substrate and inhibitor binding to
 oxidised and reduced enzyme forms, and quantifies differences between substrates and inhibitors in this regard. When combined
 with plate reader-based experimental techniques that allow large numbers of substrate and inhibitor concentrations to be used,
 and the global nonlinear regression facilities of GraphPad Prism software, this straightforward approach allows more appropriate
 analyses of monoamine oxidase by non-experts than has previously been possible.
 
 
	Content Type Journal ArticlePages 1-17DOI 10.1007/s00702-011-0657-yAuthors
		Rona R. Ramsay, School of Biology, Bio...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915485</comments>
            <pubDate>Sat, 04 Jun 2011 05:52:14 +0100</pubDate>
            <guid isPermaLink="false">4915485</guid>        </item>
        <item>
            <title>Clavulanic acid does not affect convulsions in acute seizure tests in mice</title>
            <link>http://www.medworm.com/index.php?rid=4896776&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr47628pv22118871%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Clavulanic acid (CLAV) inhibits bacterial β-lactamases and is commonly used to aid antibiotic therapy. Prompted by the initial
 evidence suggestive of the potential anticonvulsant and neuroprotective properties of CLAV, the present study was undertaken
 to systematically evaluate its acute effects on seizure thresholds in seizure tests typically used in primary screening of
 potential antiepileptic drugs (AEDs). In the present study, 6-Hz seizure threshold, maximal electroshock seizure threshold
 (MEST) test, and intravenous pentylenetetrazole (i.v. PTZ) seizure tests were used to determine anticonvulsant effects of
 intraperitoneally (i.p.) administered CLAV in mice. Acute effects on motor coordination and muscle strength were assessed
 in the chimney and grip-strengt...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896776</comments>
            <pubDate>Fri, 03 Jun 2011 05:58:46 +0100</pubDate>
            <guid isPermaLink="false">4896776</guid>        </item>
        <item>
            <title>Substantia nigra echogenicity in Parkinson’s disease: relation to serum iron and C-reactive protein</title>
            <link>http://www.medworm.com/index.php?rid=4896778&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F17n327061238776p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In Parkinson’s disease (PD), substantia nigra hyperechogenicity (SN-h) has been related to both, local iron accumulation and
 microglia activation. We analysed its relationship in PD patients with serum iron (n&amp;nbsp;=&amp;nbsp;31) and C-reactive protein (CRP; n&amp;nbsp;=&amp;nbsp;193). SN-h correlated with lower CRP and iron levels. Also, patients with a first-degree relative with PD had lower iron
 levels. Microglia activation, if reflected by SN-h, may be therefore unrelated to serum CRP. Findings support the idea that
 SN-h indicates inherited alteration of iron metabolism.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00702-011-0664-zAuthors
		Uwe Walter, Department of Neurology, University of Rostock, Gehlsheimer Str. 20, 18147 Rostock, GermanyRike Witt, Department...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896778</comments>
            <pubDate>Tue, 31 May 2011 05:52:30 +0100</pubDate>
            <guid isPermaLink="false">4896778</guid>        </item>
        <item>
            <title>Set shifting and working memory in adults with attention-deficit/hyperactivity disorder</title>
            <link>http://www.medworm.com/index.php?rid=4896777&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F95672536873127v5%2F</link>
            <description>This study compared 37 adults with ADHD (ADHDtotal) and 32 control participants who were equivalent in age, intelligence quotient (IQ), sex, and years of education, in two
 domains of EF—set shifting and working memory. Additionally, the ADHDtotal group was subdivided into two subgroups: ADHD patients without comorbidity (ADHD−, n&amp;nbsp;=&amp;nbsp;19) and patients with at least one comorbid disorder (ADHD+, n&amp;nbsp;=&amp;nbsp;18). Participants fulfilled two measures for set shifting (i.e., the trail making test, TMT and a computerized card sorting
 test, CKV) and one measure for working memory (i.e., digit span test, DS). Compared to the control group the ADHDtotal group displayed deficits in set shifting and working memory. The differences between the groups were of medium-to-large effect
 size...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896777</comments>
            <pubDate>Tue, 31 May 2011 05:52:30 +0100</pubDate>
            <guid isPermaLink="false">4896777</guid>        </item>
        <item>
            <title>Biological and psychosocial environmental risk factors influence symptom severity and psychiatric comorbidity in children with ADHD</title>
            <link>http://www.medworm.com/index.php?rid=4896779&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4321605h1315862%2F</link>
            <description>This study adds to the body of evidence that non-genetic biological and psychosocial risk factors have an impact
 on ADHD symptom severity and differentially influence comorbid disorders in ADHD. The findings are relevant to the prevention
 and treatment of ADHD with or without comorbid disorders.
 
 
	Content Type Journal ArticlePages 1-14DOI 10.1007/s00702-011-0659-9Authors
		Christine M. Freitag, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, JW Goethe University, Deutschordenstraße 50, 60528 Frankfurt am Main, GermanySusann Hänig, Department of Child and Adolescent Psychiatry, Saarland University Hospital, Homburg, GermanyAnna Schneider, Department of Child and Adolescent Psychiatry, Saarland University Hospital, Homburg, GermanyChristiane Seitz, Dep...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896779</comments>
            <pubDate>Tue, 31 May 2011 05:52:28 +0100</pubDate>
            <guid isPermaLink="false">4896779</guid>        </item>
        <item>
            <title>Kynurenines and intestinal neurotransmission: the role of N-methyl-d-aspartate receptors</title>
            <link>http://www.medworm.com/index.php?rid=4896780&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk8146106735w7215%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gastrointestinal neuroprotection involves the net effect of many mechanisms which protect the enteral nervous system and its
 cells from death, dysfunction or degeneration. Neuroprotection is also a therapeutic strategy, aimed at slowing or halting
 the progression of primary neuronal loss following acute or chronic diseases. The neuroprotective properties of a compound
 clearly have implications for an understanding of the mechanism of dysfunctions and for therapeutic approaches in a number
 of gastrointestinal diseases.
 
 
 This paper focused on the roles of glutamate and N-methyl-d-aspartate (NMDA) receptors in the intrinsic neuronal control of gastrointestinal motility; the consequences of inflammation
 on gastrointestinal motility changes; and the involvement of t...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896780</comments>
            <pubDate>Thu, 26 May 2011 16:09:37 +0100</pubDate>
            <guid isPermaLink="false">4896780</guid>        </item>
        <item>
            <title>Monoamine oxidase A regulates neural differentiation of murine embryonic stem cells</title>
            <link>http://www.medworm.com/index.php?rid=4896781&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk3gmg524154454w8%2F</link>
            <description>In this study, wild-type (WT) and MAO Aneo embryonic stem (ES) cell lines were established from the inner cell mass of murine blastocysts and their characteristics
 during ES and differentiating stages were studied. Our results show that the differentiation to neural cells in MAO Aneo ES cells was reduced compared to WT, suggesting MAO A played a regulatory role in stem cells neural differentiation.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00702-011-0655-0Authors
		Zhi-qiang Wang, Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089-9121, USAKevin Chen, Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089-9121, USAQi-l...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896781</comments>
            <pubDate>Mon, 23 May 2011 16:50:45 +0100</pubDate>
            <guid isPermaLink="false">4896781</guid>        </item>
        <item>
            <title>Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients</title>
            <link>http://www.medworm.com/index.php?rid=4856318&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5180326943227087%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic daily headache (CDH) located in the frontal region is a common problem. We have previously described the positive
 results that were achieved with botulinum toxin (BTX) injections in the musculus corrugator supercilii (MCS) for this disorder.
 Nowadays, we offer transection of this muscle to patients following a minimum of two BTX injections, provided these injections
 result in a significant reduction of pain. This procedure is based on the assumption that the pathophysiological mechanism
 in some of these patients suffering from CDH is a neural entrapment of the supratrochlear nerve in the corrugator muscle.
 To assess the effect of transection, we have evaluated all the consecutive patients (n&amp;nbsp;=&amp;nbsp;10) so far. Treatment was successful in nine of these ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4856318</comments>
            <pubDate>Thu, 19 May 2011 16:30:16 +0100</pubDate>
            <guid isPermaLink="false">4856318</guid>        </item>
        <item>
            <title>Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients</title>
            <link>http://www.medworm.com/index.php?rid=4856319&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl034085u67k63792%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The links between Stn DBS and advanced Parkinson disease, and between GPi DBS and dystonia are nearly universally accepted
 by the neurologists and neurosurgeons. Nevertheless, in some conditions, targets such as the ventral thalamus and the Zona
 Incerta may be considered to optimize the results and avoid the side effects. Positive and negative aspects of current DBS
 treatments justify the research of new targets, new stimulation programs and new hardware. Since 1993, at the Istituto Nazionale
 Neurologico “Carlo Besta” in Milan, 580 deep brain electrodes were implanted in 332 patients. 276 patients were affected by
 movement disorders. The DBS targets included Stn, GPi, Voa, Vop, Vim, CM–pf, cZi, IC. The long-term follow-up is reported
 and related to the chose...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4856319</comments>
            <pubDate>Thu, 19 May 2011 16:30:15 +0100</pubDate>
            <guid isPermaLink="false">4856319</guid>        </item>
        <item>
            <title>Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures</title>
            <link>http://www.medworm.com/index.php?rid=4807661&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2563913460673414%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sequence variants at or near the leucine-rich repeat kinase 2 (LRRK2) locus have been associated with susceptibility to three human conditions: Parkinson's disease (PD), Crohn’s disease and
 leprosy. As all three disorders represent complex diseases with evidence of inflammation, we hypothesized a role for LRRK2 in immune cell functions. Here, we report that full-length Lrrk2 is a relatively common constituent of human peripheral blood
 mononuclear cells (PBMC) including affinity isolated, CD14+ monocytes, CD19+ B cells, and CD4+ as well as CD8+ T cells. Up to 26% of PBMC from healthy donors and up to 43% of CD14+ monocytes were stained by anti-Lrrk2 antibodies using cell sorting. PBMC lysates contained full-length (&amp;gt;260&amp;nbsp;kDa) and higher
 molecular weight Lrrk2...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4807661</comments>
            <pubDate>Fri, 06 May 2011 16:18:16 +0100</pubDate>
            <guid isPermaLink="false">4807661</guid>        </item>
        <item>
            <title>Fronto-temporal lobar degeneration: neuropathology in 60 cases</title>
            <link>http://www.medworm.com/index.php?rid=4791239&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh354708131586537%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sixty cases of frontotemporal lobar degeneration (FTLD) were collected over 22&amp;nbsp;years. Brain weight was negatively correlated
 with disease duration. The neuronal and/or glial inclusions were labeled by anti-TDP, anti-FUS or anti-TAU antibodies, respectively,
 in 40, 3 and 12 cases. In the FTLD-TDP group, mutation of the progranulin gene was found in four cases (FTD-GRN), with nuclear, cat eye inclusions and severe neuronal
 loss in CA1 and subiculum. The motor neurons were involved in 27 cases (fronto-temporal dementia with amyotrophic lateral
 sclerosis&amp;nbsp;=&amp;nbsp;FTD-ALS). Familial FTD-ALS cases lived longer than sporadic ones. In nine cases, there was no ALS, no GRN mutation
 (FTD-NAP). The cases in the FTD-ALS and FTD-NAP subgroups were of Sampathu type 2 (TDP...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4791239</comments>
            <pubDate>Tue, 03 May 2011 15:33:42 +0100</pubDate>
            <guid isPermaLink="false">4791239</guid>        </item>
        <item>
            <title>Prof. Dr. Kurt Jellinger: an appreciation on the occasion of his anniversary</title>
            <link>http://www.medworm.com/index.php?rid=4784097&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F30q2786783772719%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00702-011-0652-3

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4784097</comments>
            <pubDate>Sun, 01 May 2011 05:42:20 +0100</pubDate>
            <guid isPermaLink="false">4784097</guid>        </item>
        <item>
            <title>Chromogranin peptides in brain diseases</title>
            <link>http://www.medworm.com/index.php?rid=4784098&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa82jwhr271772043%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Synaptic disturbances may play a key role in the pathophysiology of neuropsychiatric diseases. In this article, we review
 immunohistological findings of chromogranin peptides in neurodegenerative and neurodevelopmental disorders, with particular
 emphasis on Alzheimer’s disease, the disorder chromogranins have been studied most extensively. Data was collected from existing
 and new experimental data and medline research. This review focuses on synaptic changes elicited by chromogranin peptides
 immunoreactivity in Alzheimer’s disease, as well in schizophrenia and amyotrophic lateral sclerosis (ALS). An imbalanced availability
 of chromogranin peptides may be responsible for impaired neurotransmission and a reduced functioning of dense core vesicles.
 Since chromogr...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4784098</comments>
            <pubDate>Fri, 29 Apr 2011 15:46:36 +0100</pubDate>
            <guid isPermaLink="false">4784098</guid>        </item>
        <item>
            <title>Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study</title>
            <link>http://www.medworm.com/index.php?rid=4784099&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhwl4jq38v861h282%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cerebral amyloid angiopathy is manifested as accumulation of amyloid β (Aβ) peptide in the wall of meningeal and cerebral
 arteries, arterioles and capillaries and is frequently found postmortem in sporadic Alzheimer’s disease (sAD) patients. It
 is difficult to assess when and how cerebral amyloid angiopathy develops and progresses in humans in vivo, which is why animal
 AD models are used. Streptozotocin-intracerebroventricularly (STZ-icv) treated rats have been recently proposed as the model
 of sAD which develops insulin resistant brain state preceding Aβ pathology development. Vascular Aβ deposits in the brain
 of STZ-icv-treated rats (3&amp;nbsp;months old at the time of icv treatment) were visualized by Thioflavine-S staining, Congo red staining
 and Aβ immuno...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4784099</comments>
            <pubDate>Fri, 29 Apr 2011 15:46:35 +0100</pubDate>
            <guid isPermaLink="false">4784099</guid>        </item>
        <item>
            <title>Emotional processing affects movement speed</title>
            <link>http://www.medworm.com/index.php?rid=4769023&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl2u347232u10002g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Emotions can affect various aspects of human behavior. The impact of emotions on behavior is traditionally thought to occur
 at central, cognitive and motor preparation stages. Using EMG to measure the effects of emotion on movement, we found that
 emotional stimuli differing in valence and arousal elicited highly specific effects on peripheral movement time. This result
 has conceptual implications for the emotion–motion link and potentially practical implications for neurorehabilitation and
 professional environments where fast motor reactions are critical.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s00702-011-0627-4Authors
		Thomas D. Hälbig, Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USAJoan C. Borod, Department of Neu...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4769023</comments>
            <pubDate>Tue, 26 Apr 2011 05:42:51 +0100</pubDate>
            <guid isPermaLink="false">4769023</guid>        </item>
        <item>
            <title>Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells</title>
            <link>http://www.medworm.com/index.php?rid=4769022&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv432201l13l57767%2F</link>
            <description>In this study, by extending the analysis to several caspase activities
 (i.e. caspase 2, 3, 6, 8 and 9), we describe genotype- and time- dependent caspase activity abnormalities, decreased cell
 viability and a large set of alterations in mitochondria morphology, in cultured blood cells from HD patients. Patients homozygous
 for CAG repeat mutations and heterozygous with high size mutations causing juvenile onset (JHD) presented significantly increased
 caspase 2, 3, 6, 8 and 9 activities, decreased cell viability and pronounced morphological abnormalities, compared with cells
 carrying low mutation size and controls. After cyanide treatment, all caspases increased their activities in homozygous and
 highly expanded heterozygous cells, caspase 8 and 9 increased also in those cells carrying...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4769022</comments>
            <pubDate>Tue, 26 Apr 2011 05:42:51 +0100</pubDate>
            <guid isPermaLink="false">4769022</guid>        </item>
        <item>
            <title>Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study</title>
            <link>http://www.medworm.com/index.php?rid=4749637&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr5303g02764u0828%2F</link>
            <description>This study provides novel physiological evidence that MBs have an impact on central cholinergic
 function that is independent of the extent of associated white matter changes and ischaemic stroke. This finding shows that
 TMS have potential diagnostic and therapeutic implications. TMS studies may help in evaluating the causes of cognitive impairment
 in cerebrovascular diseases.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s00702-011-0650-5Authors
		Raffaele Nardone, Department of Neurology, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, AustriaPierpaolo De Blasi, Department of Economics, Collegio Carlo Alberto, University of Turin, Turin, ItalyMartin Seidl, Department of Neurology, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, AustriaYvon...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4749637</comments>
            <pubDate>Sat, 23 Apr 2011 15:41:59 +0100</pubDate>
            <guid isPermaLink="false">4749637</guid>        </item>
        <item>
            <title>Hepatic consequences of vascular adhesion protein-1 expression</title>
            <link>http://www.medworm.com/index.php?rid=4749638&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff652n356n6g65412%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The liver is constantly exposed to antigens present in the blood and to particulate antigens delivered from the gut. To maintain
 effective levels of immune surveillance and yet tolerate food antigens, the hepatic environment has become highly specialised.
 A low flow environment exists within the hepatic sinusoids that not only facilitates the exchange of toxins and nutrients
 within the liver parenchyma, but also provides an ideal niche for the recruitment of leukocytes. One such adhesion molecule
 involved in this process, the vascular adhesion protein-1 (VAP-1), is unusual in the context of the leukocyte adhesion cascade
 in that it is both an adhesion molecule and a primary amine oxidase. In this review, we examine the biological functions of
 VAP-1 and examine wha...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4749638</comments>
            <pubDate>Thu, 21 Apr 2011 18:01:25 +0100</pubDate>
            <guid isPermaLink="false">4749638</guid>        </item>
        <item>
            <title>Activation of cellular chemotactic responses to chemokines coupled with oxidation of plasma membrane proteins by lysyl oxidase</title>
            <link>http://www.medworm.com/index.php?rid=4749639&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd8872360ttj833u2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lysyl oxidase (LOX) is a potent chemokine inducing the migration of varied cell types. Here we demonstrate that inhibition
 of cellular LOX activity by preincubation of vascular smooth muscle cells (VSMC) with β-aminopropionitrile (BAPN), the irreversible
 inhibitor of LOX activity, resulted in the marked suppression of the chemotactic response and sensitivity of these cells toward
 LOX and toward PDGF-BB. Plasma membranes purified from VSMC not previously exposed to BAPN contained a group of oxidized plasma
 membrane proteins, including the PDGF receptor, PDGFR-β. The oxidation of this receptor and other membrane proteins was largely
 prevented in cells preincubated with BAPN. Addition of purified LOX to BAPN-free cells, which had been previously exposed
 to BAPN, re...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4749639</comments>
            <pubDate>Thu, 21 Apr 2011 06:14:20 +0100</pubDate>
            <guid isPermaLink="false">4749639</guid>        </item>
        <item>
            <title>Repeated co-administrations of alcohol- and methamphetamine-produced anxiogenic effect could be associated with the neurotoxicity in the dentate gyrus</title>
            <link>http://www.medworm.com/index.php?rid=4745410&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff37u1782078t80w2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To date, joint use of alcohol (EtOH) and methamphetamine (MA) represents a specific combination of polydrug abuse. Repeated
 administrations of EtOH, MA, and combined EtOH and MA were assessed for their effects on brain cell toxicity, cell mitosis
 and anxiety/depression-like behavior. We found that repeated co-administrations of EtOH and MA produced profound anxiogenic
 effects. Specifically, combined EtOH and MA decreased open arm exploratory responses in the elevated plus maze test. Moreover,
 combined EtOH and MA significantly decreased immobile responses in the tail suspension test. MA, EtOH, and their combination
 all reduced the number of NeuN-positive cells in amygdala (Amg), while neither of them altered the number of NeuN-positive
 cells in striatum (St) or pr...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745410</comments>
            <pubDate>Sun, 17 Apr 2011 05:49:20 +0100</pubDate>
            <guid isPermaLink="false">4745410</guid>        </item>
        <item>
            <title>Altered affinity of the platelet vesicular monoamine transporter 2 to dihydrotetrabenazine in children with major depression</title>
            <link>http://www.medworm.com/index.php?rid=4727359&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1726316372x6m37x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Platelet vesicular monoamine transporter (VMAT2) binding characteristics were assessed, using high affinity dihydrotetrabenazine
 ([3H]TBZOH) binding, in 14 children with major depression (MDD) and 16 matched controls. All participants underwent a thorough
 diagnostic evaluation and the levels of depression and anxiety were measured. K
 d values were significantly lower in children with MDD versus controls (2.93&amp;nbsp;±&amp;nbsp;0.84 vs. 3.63&amp;nbsp;±&amp;nbsp;0.56&amp;nbsp;nM, respectively, t&amp;nbsp;=&amp;nbsp;2.4, df&amp;nbsp;=&amp;nbsp;18.4, p&amp;nbsp;=&amp;nbsp;0.025). B
 max values did not differ significantly. This preliminary finding indicates a possible structural change in platelet VMAT2 in
 children with MDD.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00702-011-0643-4Authors
		Gil ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4727359</comments>
            <pubDate>Tue, 12 Apr 2011 06:52:04 +0100</pubDate>
            <guid isPermaLink="false">4727359</guid>        </item>
        <item>
            <title>Targeting of the pedunculopontine nucleus by an MRI-guided approach: a cadaver study</title>
            <link>http://www.medworm.com/index.php?rid=4706036&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx801j85025785j21%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Laboratory evidence suggests that the pedunculopontine nucleus (PPN) plays a central role in the initiation and maintenance
 of gait. Translational research has led to reports on deep brain stimulation (DBS) of the rostral brainstem in parkinsonian
 patients. However, initial clinical results appear to be rather variable. Possible factors include patient selection and the
 wide variability in anatomical location of implanted electrodes. Clinical studies on PPN DBS efficacy would, therefore, benefit
 from an accurate and reproducible method of stereotactic localization of the nucleus. The present study evaluates the anatomical
 accuracy of a specific protocol for MRI-guided stereotactic targeting of the PPN in a human cadaver. Imaging at 1.5 and 9.4&amp;nbsp;T
 confirmed ele...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706036</comments>
            <pubDate>Mon, 11 Apr 2011 15:45:53 +0100</pubDate>
            <guid isPermaLink="false">4706036</guid>        </item>
        <item>
            <title>Neurophysiological evaluation of the pedunculopontine nucleus in humans</title>
            <link>http://www.medworm.com/index.php?rid=4706037&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6g721052355328r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pedunculopontine nucleus (PPTg) is constituted by a heterogeneous cluster of neurons located in caudal mesencephalic tegmentum
 which projects to the thalamus to trigger thalamocortical rhythms and the brainstem to modulate muscle tone and locomotion.
 It has been investigated as potential deep brain stimulation (DBS) target for treating Parkinson’s disease (PD) symptoms.
 Neurophysiological studies conducted in humans using DBS electrodes for exploring functional properties of PPTg in vivo, reviewed
 in this paper, demonstrated that the functional connections between PPTg and cortex, basal ganglia, brainstem network involved
 in sleep/wake control, and spinal cord can be explored in vivo and provided useful insights about the physiology of this nucleus
 and patho...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706037</comments>
            <pubDate>Sun, 10 Apr 2011 05:51:35 +0100</pubDate>
            <guid isPermaLink="false">4706037</guid>        </item>
        <item>
            <title>A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force</title>
            <link>http://www.medworm.com/index.php?rid=4706038&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm0764687l6655612%2F</link>
            <description>In conclusion, formal neuropsychology and longitudinal follow-up are still required for
 the diagnosis and categorization of dementia in PD.
 
 
	Content Type Journal ArticlePages 1-4DOI 10.1007/s00702-011-0638-1Authors
		M. E. Di Battista, Centro Parkinson D.A.I. Neurologia e Pischiatria Policlinico Universitario Umberto I, “Sapienza” Università di Roma, Viale dell’Università 30, 00185 Rome, ItalyP. Giustini, Centro Parkinson D.A.I. Neurologia e Pischiatria Policlinico Universitario Umberto I, “Sapienza” Università di Roma, Viale dell’Università 30, 00185 Rome, ItalyS. Bernardi, Centro Parkinson D.A.I. Neurologia e Pischiatria Policlinico Universitario Umberto I, “Sapienza” Università di Roma, Viale dell’Università 30, 00185 Rome, ItalyP. Stirpe, Centro Parkinson D...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706038</comments>
            <pubDate>Sat, 09 Apr 2011 15:49:17 +0100</pubDate>
            <guid isPermaLink="false">4706038</guid>        </item>
        <item>
            <title>Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4706039&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgq040701w263vuj0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Professor Jellinger first identified that striatal Aβ deposition at postmortem seemed to differentiate cases of dementia with
 Lewy bodies (DLB) from those with Parkinson’s disease dementia (PDD), a finding subsequently questioned. Our replication study
 in 34 prospectively studied cases assessed the ability of striatal Aβ deposition to differentiate DLB from PDD, and also assessed
 the relationship between striatal and cortical Aβ deposition and α-synuclein-immunoreactive pathologies, using previously
 published protocols. Cases with DLB had significantly shorter durations and greater dementia severities compared with cases
 with PDD. Striatal Aβ-immunoreactive plaques were only consistently found in cases with DLB and correlated with both the severity
 (positiv...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706039</comments>
            <pubDate>Sat, 09 Apr 2011 05:50:13 +0100</pubDate>
            <guid isPermaLink="false">4706039</guid>        </item>
        <item>
            <title>Ginkgo extract EGb 761® shields from slowly accumulating neurodegenerative-like changes in a newly developed cell culture model induced by the combined action of low doses of antimycin A1 and 2-deoxy-d-glucose</title>
            <link>http://www.medworm.com/index.php?rid=4706040&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy71v01t732w11386%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Different cell culture models were already used to analyze the molecular base of the neuroprotective activities of the Ginkgo biloba extract EGb 761® after a single or short-term application. In these previous studies cells were severely injured with agents that promptly
 induce fatal cellular damage, like vast oxidative stress or mitochondrial dysfunction, and the protective effects of EGb 761® on such acute damage were evaluated. Our present study aimed to test EGb 761® action in cell cultures, where cellular functions are only moderately impaired by a longer lasting, but relatively modest
 oxidative stress, reduction of mitochondrial function and reduced intracellular energy levels, thereby causing only slow occurence
 of cellular damage over a time period of 2&amp;nb...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706040</comments>
            <pubDate>Sat, 09 Apr 2011 05:50:12 +0100</pubDate>
            <guid isPermaLink="false">4706040</guid>        </item>
        <item>
            <title>Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats</title>
            <link>http://www.medworm.com/index.php?rid=4706042&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9394243531781714%2F</link>
            <description>In conclusion, V. officinalis had behavioral protective effect against reserpine-induced VCMs in rats; however, the exact mechanisms that contributed to
 this effect have not been completely understood.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s00702-011-0640-7Authors
		Romaiana Picada Pereira, Departamento de Química, Programa de Pós-Graduação em Bioquímica Toxicológica, Universidade Federal de Santa Maria, Santa Maria, RS, BrazilRoselei Fachinetto, Departamento de Fisiologia e Farmacologia, Programa de Pós-Graduação em Farmacologia, and Programa de Pós-Graduação em Bioquímica Toxicológica, Universidade Federal de Santa Maria, Santa Maria, RS, BrazilAlessandro de Souza Prestes, Departamento de Química, Programa de Pós-Graduação em Bioquímica Toxicológica,...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706042</comments>
            <pubDate>Fri, 08 Apr 2011 07:06:52 +0100</pubDate>
            <guid isPermaLink="false">4706042</guid>        </item>
        <item>
            <title>Computational investigation on the structure–activity relationship of the biradical mechanism for monoamine oxidase</title>
            <link>http://www.medworm.com/index.php?rid=4706041&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr1444680535113v7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although a considerable amount of mechanistic data has accumulated in literature, the detailed mechanism for amine oxidation
 by monoamine oxidase is still controversial. The single electron transfer mechanism (SET) has been widely discussed, but not
 completely understood yet. In the present study, the modified SET mechanism, proposed by Silverman et al., was explored by
 quantum chemical calculations. The ONIOM method was applied with UDFT/B3LYP/6-31&amp;nbsp;+&amp;nbsp;G(d,p) for the higher layer and with UHF/6-31G(d)
 for the lower layer. Isoalloxazin heterocyclic ring and benzylamine were employed in the calculations to represent flavin
 and the substrate, respectively. The substituents CH3, OH, OCH3, H, F, Cl, Br, CF3 and NO2 were incorporated at the para position of benz...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706041</comments>
            <pubDate>Fri, 08 Apr 2011 07:06:52 +0100</pubDate>
            <guid isPermaLink="false">4706041</guid>        </item>
        <item>
            <title>Increase expression of α-synuclein in aged human brain associated with neuromelanin accumulation</title>
            <link>http://www.medworm.com/index.php?rid=4678420&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnm83715l6m370j61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although the increased prevalence of Parkinson’s disease (PD) with aging suggests that aging processes predispose dopamine
 neurons to degeneration, the mechanism involved remains unknown. Dopamine neurons contain significant amounts of neuromelanin,
 and the amount of neuromelanin increases with aging. In the present study, age-related changes in the number of nigral neurons
 expressing neuromelanin (NM), α-synuclein, and tyrosine hydroxylase (TH) were stereologically analyzed in the postmortem brains
 of 28 healthy humans with an age range of 17–84&amp;nbsp;years. Stereological counting of NM content, α-synuclein content, and TH immunoreactivity
 revealed significant accumulation of NM and α-synuclein in neurons during the aging process. In cells containing a large...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678420</comments>
            <pubDate>Sun, 03 Apr 2011 05:53:58 +0100</pubDate>
            <guid isPermaLink="false">4678420</guid>        </item>
        <item>
            <title>Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4678421&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63n67x7g82jw2804%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Former studies on the effects of physical exercise, physical and occupational therapy (PT, OT) and speech and swallowing therapy
 (ST, SwT) in Parkinson’s disease (PD) have demonstrated little or uncertain effects. New pathophysiological concepts have
 been developed. Recent controlled high-level studies demonstrate improvement of mobility and balance after training of muscular
 strength and endurance, trunk control, and amplitude and rhythmicity of movements (treadmill). Attentional and cognitive strategies
 were found to enforce body awareness and improve movement sequences. Dance, sensory (auditory, visual, tactile) and cognitive
 cueing are effective for problems of gait and balance. Whether PT and OT reduce the risk of falls remains uncertain. ST including
 Lee S...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678421</comments>
            <pubDate>Sun, 03 Apr 2011 05:53:57 +0100</pubDate>
            <guid isPermaLink="false">4678421</guid>        </item>
        <item>
            <title>Memantine in moderate to severe Alzheimer’s disease: an observational post-marketing study</title>
            <link>http://www.medworm.com/index.php?rid=4678423&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F36364r30m4nr666q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Memantine is an N-methyl-d-aspartate (NMDA) receptor antagonist, approved for the treatment of moderate to severe Alzheimer’s disease (AD). We conducted
 a 4-month observational, post-marketing, Austrian study of memantine in 377 outpatients with moderate to severe AD. In this
 ‘real-life’ setting, memantine was well-tolerated, and produced benefits in cognition (Mini-Mental State Examination), activities
 of daily living (Activities of Daily Living score), and global function (Clinical Global Impression scale). Treatment effects
 were apparent in both pre-treated and treatment-naïve patient subgroups.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s00702-011-0623-8Authors
		Michael Rainer, Memory Clinic and Psychiatric Department, Donauspital Sozialmedizi...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678423</comments>
            <pubDate>Sat, 02 Apr 2011 05:56:11 +0100</pubDate>
            <guid isPermaLink="false">4678423</guid>        </item>
        <item>
            <title>A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice</title>
            <link>http://www.medworm.com/index.php?rid=4678422&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk233w127j0432889%2F</link>
            <description>In this study, we assessed the effects of two glycine/NMDA receptor ligands, namely L-701,324 (antagonist) and d-cycloserine (a partial agonist) on the action of antidepressant drugs with different pharmacological profiles in the forced
 swim test in mice. Swim sessions were conducted by placing mice individually in glass cylinders filled with warmed water for
 6&amp;nbsp;min. The duration of behavioral immobility during the last 4&amp;nbsp;min of the test was evaluated. The locomotor activity of mice
 was measured with photoresistor actimeters. L-701,324 and d-cycloserine given with reboxetine (administered in subeffective doses) did not change the behavior of animals in the forced
 swim test. A potentiating effect was seen when both tested glycine site ligands were given concomitantly with imipr...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678422</comments>
            <pubDate>Sat, 02 Apr 2011 05:56:11 +0100</pubDate>
            <guid isPermaLink="false">4678422</guid>        </item>
        <item>
            <title>Editorial comments</title>
            <link>http://www.medworm.com/index.php?rid=4678424&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07j900r4q83n1202%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00702-011-0633-6Authors
		Amos D. Korczyn, Tel Aviv, Israel
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678424</comments>
            <pubDate>Fri, 01 Apr 2011 05:44:21 +0100</pubDate>
            <guid isPermaLink="false">4678424</guid>        </item>
        <item>
            <title>Asymptomatic carotid artery stenosis (ACAS)</title>
            <link>http://www.medworm.com/index.php?rid=4678425&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx54178wuj5555m35%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00702-011-0634-5

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678425</comments>
            <pubDate>Fri, 01 Apr 2011 05:44:19 +0100</pubDate>
            <guid isPermaLink="false">4678425</guid>        </item>
        <item>
            <title>Editorial comments</title>
            <link>http://www.medworm.com/index.php?rid=4660155&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxm1424h91748q028%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00702-011-0632-7Authors
		Alan M. Rapoport, The David Geffen School of Medicine at UCLA, Los Angeles, CA USA
	

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4660155</comments>
            <pubDate>Tue, 29 Mar 2011 17:31:38 +0100</pubDate>
            <guid isPermaLink="false">4660155</guid>        </item>
        <item>
            <title>Pedunculopontine stimulation from primate to patient</title>
            <link>http://www.medworm.com/index.php?rid=4660156&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe227635475381158%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) is a novel neurosurgical therapy developed to address symptoms
 of gait freezing and postural instability in Parkinson’s disease and related disorders. Here we summarise our non-human primate
 investigations of relevance to our surgical targeting of the PPN and relate the primate research to initial clinical experience
 of PPN DBS.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s00702-011-0631-8Authors
		Erlick A. C. Pereira, Oxford Functional Neurosurgery, Department of Neurological Surgery, The West Wing, The John Radcliffe Hospital, Oxford, OX3 9DU UKDipankar Nandi, Imperial College Neuromodulation Group, Charing Cross Hospital and Division of Neuroscience and Mental Health, Imperial College ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4660156</comments>
            <pubDate>Tue, 29 Mar 2011 17:31:37 +0100</pubDate>
            <guid isPermaLink="false">4660156</guid>        </item>
        <item>
            <title>Family-based association analysis of alcohol dependence in the COGA sample and replication in the Australian twin-family study</title>
            <link>http://www.medworm.com/index.php?rid=4660158&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F31kuu66731v1503l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Family, twin, and adoption studies have indicated that genetic and environmental factors contribute to the development of
 alcohol dependence (AD). We conducted a low-density genome-wide association analysis to identify genetic variants influencing
 AD. We used 11,120 SNPs from the Affymetrix 10K Genechips genotyped in 116 Caucasian pedigrees (272 nuclear families) from
 Genetic Analysis Workshop 14, a subset from the Collaborative Study on the Genetics of Alcoholism (COGA). Family-based association
 analyses for AD were performed by the PBAT program for autosomal SNPs and by the FBAT program for X-chromosome SNPs. We identified
 37 SNPs associated with AD (P&amp;nbsp;&amp;lt;&amp;nbsp;10−3), thirteen of which were located in known genes. The most significant association with AD ...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4660158</comments>
            <pubDate>Tue, 29 Mar 2011 07:02:03 +0100</pubDate>
            <guid isPermaLink="false">4660158</guid>        </item>
        <item>
            <title>Variation in genes involved in dopamine clearance influence the startle response in older adults</title>
            <link>http://www.medworm.com/index.php?rid=4660157&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32k277824pj58280%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The dopamine transporter (DAT) and the enzyme catechol-O-methyltransferase (COMT) both terminate synaptic dopamine action. Here, we investigated the influence of two polymorphisms
 in the respective genes: DAT1 (SLC6A3) VNTR and COMT val158met (rs4680). Startle magnitudes to intense noise bursts as measured with the eye blink response were recorded during the
 presentation of pictures of three valence conditions (unpleasant, pleasant and neutral) and during baseline without additional
 pictorial stimulation in a sample of healthy older adults (N&amp;nbsp;=&amp;nbsp;94). There was a significant Bonferroni corrected main effect of COMT genotype on the overall startle responses, with met/met homozygotes showing the highest and participants with the val/val
 genotype showing the lo...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4660157</comments>
            <pubDate>Tue, 29 Mar 2011 07:02:03 +0100</pubDate>
            <guid isPermaLink="false">4660157</guid>        </item>
        <item>
            <title>Exercise inhibits neuronal apoptosis and improves cerebral function following rat traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=4646176&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe841w91155173j62%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exercise is reported to inhibit neuronal apoptotic cell death in the hippocampus and improve learning and memory. However,
 the effect of exercise on inhibition of neuronal apoptosis surrounding the area of damage after traumatic brain injury (TBI)
 and the improvement of cerebral dysfunction following TBI are unknown. Here, we investigate the effect of exercise on morphology
 and cerebral function following TBI in rats. Wistar rats received TBI by a pneumatic controlled injury device were randomly
 divided into two groups: (1) non-exercise group and (2) exercise group. The exercise group ran on a treadmill for 30&amp;nbsp;min/day
 at 22&amp;nbsp;m/min for seven consecutive days. Immunohistochemical and behavioral studies were performed following TBI. The number
 of single-stra...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4646176</comments>
            <pubDate>Sun, 27 Mar 2011 05:46:17 +0100</pubDate>
            <guid isPermaLink="false">4646176</guid>        </item>
        <item>
            <title>Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice</title>
            <link>http://www.medworm.com/index.php?rid=4646177&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd311g06786tg10t8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neuropathological features in Alzheimer’s Disease (AD) include the presence of hyperphosphorylated forms of the microtubule-associated
 tau protein (tau) in hippocampal neurones. Numerous studies indicate a neuroprotective effect of calcium-binding proteins
 (Ca2+ binding proteins) in neurodegenerative diseases (e.g., AD). Secretagogin is a newly described Ca2+ binding protein that
 is produced by pyramidal neurones of the human hippocampus. Recently, secretagogin expressing hippocampal neurones were demonstrated
 to resist tau-induced pathology in AD in contrast to the majority of neighbouring neurones. This suggested a neuroprotective effect of secretagogin in hippocampal neurones. Here, we investigated secretagogin expression
 in wild type (wt) mice as well as in h...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4646177</comments>
            <pubDate>Sun, 27 Mar 2011 05:46:16 +0100</pubDate>
            <guid isPermaLink="false">4646177</guid>        </item>
        <item>
            <title>Altered functional organization of the motor system related to ankle movements in Parkinson’s disease: insights from functional MRI</title>
            <link>http://www.medworm.com/index.php?rid=4646178&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb27w46036305hl4r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bradykinesia represents one of the cardinal and most incapacitating features of Parkinson’s disease (PD). In this context,
 investigating the cerebral control mechanisms for limb movements and defining the associated functional neuroanatomy is important
 for understanding the impaired motor activity in PD. So far, most studies have focused on motor control of upper limb movements
 in PD. Ankle movement functional MRI (fMRI) paradigms have been used to non-invasively investigate supraspinal control mechanisms
 relevant for lower limb movements in healthy subjects, patients with Multiple sclerosis, and stroke. Using such an active
 and passive paradigm in 20 PD patients off medication (mean age 66.8&amp;nbsp;±&amp;nbsp;7.2&amp;nbsp;years) and 20 healthy controls (HC; mean age 62.3...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4646178</comments>
            <pubDate>Fri, 25 Mar 2011 05:49:31 +0100</pubDate>
            <guid isPermaLink="false">4646178</guid>        </item>
        <item>
            <title>A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle</title>
            <link>http://www.medworm.com/index.php?rid=4617838&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F80g17406p6113p85%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Studies investigating the impact of high meat intake on cognition have yielded contradictory results as some show improved
 cognitive performance, whereas others report an increase of risk factors for dementia. However, few studies were designed
 to directly assess the effect of a high protein (HP) diet on both cognitive performance and corresponding biochemical parameters.
 A randomised intervention study was conducted with 23 healthy males (aged 19–31&amp;nbsp;years) to investigate the effects of a usual
 (UP) versus a HP diet on cognitive function and on the platelet proteome a well-established model for neurons. The study individuals
 were assigned to either a UP diet (15% energy) or a HP diet (30% energy) for 3&amp;nbsp;weeks with controlled intake of food and beverages....</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617838</comments>
            <pubDate>Sat, 19 Mar 2011 16:58:18 +0100</pubDate>
            <guid isPermaLink="false">4617838</guid>        </item>
        <item>
            <title>The norepinephrine transporter gene is a candidate gene for panic disorder</title>
            <link>http://www.medworm.com/index.php?rid=4617839&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F39w863162565241j%2F</link>
            <description>In conclusion, the present study indicates that NET could be a susceptibility gene for PD.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s00702-011-0624-7Authors
		H. N. Buttenschøn, Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Skovagervej 2, 8240 Risskov, DenmarkA. S. Kristensen, Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Skovagervej 2, 8240 Risskov, DenmarkH. N. Buch, Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Skovagervej 2, 8240 Risskov, DenmarkJ. H. Andersen, Department of Occupational Medicine, Danish Ramazzini Centre, Regional Hospital Herning, Herning, DenmarkJ. P. Bonde, Department of Occupational Medicine, Bispebjerg University Hospital, Copenhagen, DenmarkM. Grynderup, Department of Occupation...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617839</comments>
            <pubDate>Thu, 17 Mar 2011 18:36:25 +0100</pubDate>
            <guid isPermaLink="false">4617839</guid>        </item>
        <item>
            <title>Editorial</title>
            <link>http://www.medworm.com/index.php?rid=4597020&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01k5r1rg163566r7%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00702-011-0618-5

	
		Journal Journal of Neural TransmissionOnline ISSN 1435-1463Print ISSN 0300-9564 (Source: Journal of Neural Transmission)</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4597020</comments>
            <pubDate>Sat, 12 Mar 2011 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">4597020</guid>        </item>
        <item>
            <title>Tyrosine 381 in E. coli copper amine oxidase influences substrate specificity</title>
            <link>http://www.medworm.com/index.php?rid=4578798&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg1217p87t161261t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Copper amine oxidases are important for the metabolism of a range of biogenic amines. Here, we focus on substrate specificity
 in the E. coli copper amine oxidase (ECAO) and specifically the role of Tyr 381. This residue, and its equivalent, in other copper amine
 oxidases has been referred to as a “gating” residue able to move position depending upon the presence or absence of amine
 substrate. The position of this residue suggests a role in substrate selectivity. We have compared the properties of two variant
 forms of ECAO, Y381F and Y381A, with wild-type enzyme by steady-state kinetics of oxidation of a number of amine substrates,
 modes of inhibitor interactions and X-ray structure determination. Y381F displays a similar catalytic efficiency to wild type
 again...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578798</comments>
            <pubDate>Wed, 09 Mar 2011 16:48:50 +0100</pubDate>
            <guid isPermaLink="false">4578798</guid>        </item>
        <item>
            <title>Rare brain biopsy findings in a first ADEM-like event of pediatric MS: histopathologic, neuroradiologic and clinical features</title>
            <link>http://www.medworm.com/index.php?rid=4578799&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F062517266030l545%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pediatric MS tends to present more often with an acute onset and a polysymptomatic form of the disease, possibly with encephalopathy
 and large tumefactive lesions similar to those observed in some cases of acute disseminated encephalomyelitis (ADEM), which
 makes it more difficult to differentiate between an explosive and severe onset of MS vs. ADEM. An ADEM-like first demyelinating
 event can be the first attack of pediatric MS, but international consensus definitions require two or more non-ADEM demyelinating
 events for diagnosis of MS. In our patient KIDMUS MRI criteria for MS (Mikaeloff et al. J Pediatr 144:246–252, 2004a; Mikaeloff et al. Brain 127:1942–1947, 2004b) were negative at first attack, but Barkhof criteria for lesion dissemination in space in adult...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578799</comments>
            <pubDate>Wed, 09 Mar 2011 16:48:49 +0100</pubDate>
            <guid isPermaLink="false">4578799</guid>        </item>
        <item>
            <title>Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein</title>
            <link>http://www.medworm.com/index.php?rid=4578800&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4827167652k48257%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The microtubule-associated protein Tau promotes the assembly and stability of microtubules in neuronal cells. Six Tau isoforms
 are expressed in adult human brain. All six isoforms become abnormally hyperphosphorylated and form neurofibrillary tangles
 in Alzheimer disease (AD) brains. In AD, reduced activity of phospholipase A2 (PLA2), specifically of calcium-dependent cytosolic PLA2 (cPLA2) and calcium-independent intracellular PLA2 (iPLA2), was reported in the cerebral cortex and hippocampus, which positively correlated with the density of neurofibrillary tangles.
 We previously demonstrated that treatment of cultured neurons with a dual cPLA2 and iPLA2 inhibitor, methyl arachidonyl fluorophosphonate (MAFP), decreased total Tau levels and increased Tau phosphorylatio...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4578800</comments>
            <pubDate>Wed, 09 Mar 2011 07:00:41 +0100</pubDate>
            <guid isPermaLink="false">4578800</guid>        </item>
        <item>
            <title>Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4562545&amp;cid=s_33360_25_f&amp;fid=33360&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F058rw16r45382527%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple sclerosis and Alzheimer’s disease are fundamentally different diseases. However, recent data suggest that certain
 mechanisms of neurodegeneration may be shared between the two diseases. Inflammation drives the disease in multiple sclerosis.
 It is also present in Alzheimer’s disease lesions, where it may have dual functions in amyloid clearance as well as in the
 propagation of neurodegeneration. In both diseases, degeneration of neurons, axons, and synapses occur on the background of
 profound mitochondrial injury. Reactive oxygen and nitric oxide intermediates are major candidates for the induction of mitochondrial
 injury. Radicals are produced through the induction of the respiratory burst in activated microglia, which are present in
 the lesions of bo...</description>
            <author>Journal of Neural Transmission</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562545</comments>
            <pubDate>Fri, 04 Mar 2011 11:03:35 +0100</pubDate>
            <guid isPermaLink="false">4562545</guid>        </item>
    </channel>
</rss>

